[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 11378
1. Zhang C, Cui GH, Liu F, Wu QL, Chen Y: [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma]. Zhonghua Yi Xue Za Zhi; 2007 Mar 13;87(10):695-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
  • OBJECTIVE: To study the expression of stromal cell derived factor-1 (SDF-1) and its receptor CXCR4 in non-Hodgkin lymphoma (NHL), and to investigate the role of this biological axis in tumor metastasis of NHL.
  • METHODS: Specimens of bone marrow were collected from 4 patients with NHL with bone marrow infiltration and 4 cases of NHL without bone marrow infiltration, and 4 patients with benign hepatopathy with normal myelogram.
  • The level of SDF-1alpha mRNA in the stromal cells of bone marrow and lymph node were determined by RT-PCR.
  • The CXCR4 expression on lymphoma cells freshly isolated from bone marrow and lymph node of the NHL patients were studied by flow cytometry.
  • Transwell assay was performed, the upper chamber being added with suspension of cells newly isolated from lymph nodes or bone marrow undergoing co-incubation with ant-CXCR4 monoclonal antibody or not, and the lower chamber added with culture fluid with or without recombinant human SDF-1alpha (rhSDF-1alpha).
  • RESULTS: The expression levels of CXCR4 on the lymphoma cells isolated from the bone marrow involved or not involved by NHL were both significantly higher than that of the mononuclear cells from normal bone marrow (both P < 0.01), whereas the CXCR4 expression level on the lymphoma cells from the lymph nodes of the NHL patients was also significantly higher than that of the mononuclear cells from the lymph nodes of reactive proliferative lymphadenitis (P < 0.01).
  • Moreover, the SDF-1alpha expression level in the lymph node stromal cells of all the NHL patients was also significantly higher than that of the patients with reactive proliferative lymphadenitis (P < 0.01).
  • CONCLUSION: SDF-1/CXCR4 axis plays a uniquely important biological role in mediating tumor metastasis of NHL.
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Flow Cytometry. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17553309.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Chemokine CXCL12; 0 / RNA, Messenger; 0 / Receptors, CXCR4
  •  go-up   go-down


2. Bigé N, Arnulf B, Hummel A, De Keyser E, Royal V, Buzyn A, Fakhouri F: Urinary tract obstruction due to extramedullary plasmacytoma: report of two cases. NDT Plus; 2009 Apr;2(2):143-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most frequent reported sites are superior respiratory airways, pleura, lung, lymph nodes, skin, subcutaneous and soft tissues, testicles and liver.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25949312.001).
  • [ISSN] 1753-0784
  • [Journal-full-title] NDT plus
  • [ISO-abbreviation] NDT Plus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC4421342
  • [Keywords] NOTNLM ; bladder / multiple myeloma / plasmacytoma / urinary tract
  •  go-up   go-down


3. Zagha RM, Hamawy KJ: Solitary breast cancer metastasis to the bladder: an unusual occurrence. Urol Oncol; 2007 May-Jun;25(3):236-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Breast carcinoma is the most common nondermatologic cancer diagnosis in women.
  • Common metastatic sites include lymph nodes, lung, liver, and bone.
  • Only 5 of these patients were reported to have no other site of metastasis, other than axillary nodes at breast surgery.


Advertisement
4. Rowin J, Cheng G, Lewis SL, Meriggioli MN: Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease. Muscle Nerve; 2006 Nov;34(5):666-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present three cases of dropped head syndrome that occurred as a complication of mantle field (i.e., lymph nodes of the neck, axillae, and mediastinum) or whole-body radiation therapy for Hodgkin's disease.
  • [MeSH-minor] Brachial Plexus / physiopathology. Brachial Plexus / radiation effects. Brachial Plexus Neuropathies / etiology. Brachial Plexus Neuropathies / pathology. Brachial Plexus Neuropathies / physiopathology. Connective Tissue / pathology. Connective Tissue / physiopathology. Connective Tissue / radiation effects. Female. Humans. Lymph Nodes / pathology. Lymph Nodes / radiation effects. Male. Middle Aged. Radiation Dosage. Spinal Nerve Roots / physiopathology. Spinal Nerve Roots / radiation effects. Time

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16897763.001).
  • [ISSN] 0148-639X
  • [Journal-full-title] Muscle & nerve
  • [ISO-abbreviation] Muscle Nerve
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Il'in NV, Vinogradova IuN, Nikolaeva EN, Ivanova EI, Shenderova IA, Smirnova EV, Izomov BM, Trishkina EV, Kritskaia AV, Leenman EE: [Combined therapy and radiotherapy in stage-II Hodgkin disease]. Vopr Onkol; 2010;56(5):623-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It included 179 patients with involvement of supradiaphragmatic lymph nodes treated in 1986-2006.
  • [MeSH-minor] Adolescent. Adult. Aged. Disease-Free Survival. Dose Fractionation. Female. Humans. Male. Middle Aged. Neoplasm Staging. Radiotherapy Dosage. Radiotherapy, Adjuvant. Recurrence. Retrospective Studies. Survival Analysis. Time Factors. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21137247.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


6. Smolár M, Sutiak L, Mikolajcík A, Vojtko M, Plank L: [Gastric lymphoma as a cause of massive bleeding in a patient with Castleman's disease]. Rozhl Chir; 2010 May;89(5):320-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Authors in their contribution refer about the patient with the gastric lymphoma, in which was Castleman's disease diagnosed by the lymph-nodes biopsy.
  • The final histological diagnosis was aggressive B-NHL of the stomach.
  • [MeSH-major] Gastrointestinal Hemorrhage / etiology. Giant Lymph Node Hyperplasia / complications. Lymphoma, Large B-Cell, Diffuse / complications. Stomach Neoplasms / complications


7. Lee DH, Lee JH, Shim EJ, Cho DJ, Min KS, Yoo KY, Min K: Disseminated Kikuchi-Fujimoto disease mimicking malignant lymphoma on positron emission tomography in a child. J Pediatr Hematol Oncol; 2009 Sep;31(9):687-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Kikuchi-Fujimoto disease is a rare and benign disease, characterized by regional cervical lymphadenopathy with fever of unknown origin, affecting mainly young women.
  • We describe a case of a child who was initially mistaken for malignant lymphoma because of multiple lymph nodes with 18-fluorodeoxyglucose uptake on positron emission tomography and was finally diagnosed with Kikuchi-Fujimoto disease by excisional biopsy of the affected lymph node.
  • [MeSH-major] Histiocytic Necrotizing Lymphadenitis / radionuclide imaging. Lymphoma / diagnosis. Positron-Emission Tomography
  • [MeSH-minor] Biopsy. Child. Diagnosis, Differential. Fatigue / etiology. Female. Fever / etiology. Fluorine Radioisotopes. Fluorodeoxyglucose F18. Humans. Hyperplasia. Lymph Nodes / pathology. Lymph Nodes / radionuclide imaging. Necrosis. Radiopharmaceuticals. Remission Induction. Weight Loss

  • Genetic Alliance. consumer health - Kikuchi disease.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19684524.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


8. Asha LK, Thomas D, Binitha MP, Nandakumar G: Primary cutaneous multifocal CD30+ anaplastic large cell lymphoma. Indian J Dermatol Venereol Leprol; 2006 Sep-Oct;72(5):376-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were generalized, nontender, firm to hard enlarged lymph nodes without hepatosplenomegaly.
  • Primary cutaneous anaplastic large cell lymphoma is characterized by single or grouped reddish-brown tumor nodules, which frequently tend to ulcerate.
  • Secondary involvement of lymph nodes is seen in only 25%.
  • [MeSH-major] Antigens, CD30 / biosynthesis. Lymphoma, Large B-Cell, Diffuse / diagnosis. Lymphoma, Large B-Cell, Diffuse / immunology. Skin Neoplasms / diagnosis. Skin Neoplasms / immunology

  • Genetic Alliance. consumer health - Anaplastic Large Cell Lymphoma.
  • Genetic Alliance. consumer health - Lymphoma, large-cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17050936.001).
  • [ISSN] 0973-3922
  • [Journal-full-title] Indian journal of dermatology, venereology and leprology
  • [ISO-abbreviation] Indian J Dermatol Venereol Leprol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Antigens, CD30; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


9. Favaro PM, Traina F, Vassallo J, Brousset P, Delsol G, Costa FF, Saad ST: High expression of FMNL1 protein in T non-Hodgkin's lymphomas. Leuk Res; 2006 Jun;30(6):735-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, we describe the expression of the FMNL1 protein in 54 frozen biopsies of non-Hodgkin's lymphoma (NHL) patients and five reactive lymph nodes.
  • [MeSH-major] Cytoskeletal Proteins / biosynthesis. Gene Expression Regulation, Leukemic. Lymphoma, T-Cell / metabolism. Neoplasm Proteins / biosynthesis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Blotting, Western. Female. Humans. Lymph Nodes / metabolism. Lymph Nodes / pathology. Male. Middle Aged

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16494944.001).
  • [ISSN] 0145-2126
  • [Journal-full-title] Leukemia research
  • [ISO-abbreviation] Leuk. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytoskeletal Proteins; 0 / FMNL1 protein, human; 0 / Neoplasm Proteins
  •  go-up   go-down


10. Giard RW: [Prognosis in patients operated on for colorectal carcinoma: related to but not determined by number of lymph nodes examined]. Ned Tijdschr Geneeskd; 2008 Mar 15;152(11):599-602
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Prognosis in patients operated on for colorectal carcinoma: related to but not determined by number of lymph nodes examined].
  • The presence or absence of lymph node metastases is pivotal for the estimation of prognosis in carcinoma patients.
  • The presence of lymph node metastases in patients with colorectal carcinoma (CRC) is an indicator of poor prognosis and adjuvant treatment is increasingly being given to these patients.
  • In patients with TNM stage II CRC, prognosis is related to the actual number of nodes harvested: those in whom fewer nodes are harvested fare less well.
  • Understaging was suspected and therefore protocols now require a minimum number of nodes.
  • The number of nodes is not a suitable measure for the quality of pathological staging of CRC.
  • [MeSH-major] Colorectal Neoplasms / mortality. Colorectal Neoplasms / pathology. Lymph Nodes / pathology
  • [MeSH-minor] Female. Humans. Lymphatic Metastasis. Male. Neoplasm Staging. Prognosis. Survival Analysis

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18410018.001).
  • [ISSN] 0028-2162
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


11. Kazakov DV, Hes O, Hora M, Sima R, Michal M: Primary intranodal cellular angiolipoma. Int J Surg Pathol; 2005 Jan;13(1):99-101
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Angiolipoma is a distinct, benign soft tissue tumor that most commonly occurs in young males as multiple small, subcutaneous, tender to painful nodules with predilection for the forearms.
  • We report a case of angiolipoma that developed within a lymph node.
  • The prostate and 3 lymph nodes located in the obturator fossa were removed.
  • On gross examination, the cut surface of 1 of the lymph nodes revealed an 8 x 5 mm, ovoid, sharply demarcated, nonencapsulated, gray lesion being suspicious for adenocarcinoma metastasis.
  • Microscopically, the major portion of the lymph node was replaced by mature metaplastic adipose tissue.
  • Lymph nodes are known to be a rare primary site of various tumors usually occurring in other organs.
  • The most recognized examples are pigmented nevi, palisading myofibroblastoma, various benign epithelial inclusions, serous cystic tumors of borderline malignancy, and hyperplastic mesothelial inclusions.
  • As we present in this report, angiolipoma is another neoplasm whose primary occurrence in the lymph node should not be misinterpreted as a metastatic tumor or malignant vascular tumor.
  • [MeSH-major] Angiolipoma / pathology. Lymph Nodes / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adipose Tissue / pathology. Aged. Antigens, CD31 / analysis. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Lymphatic Metastasis / diagnosis. Male. Metaplasia / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15735863.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD31; 0 / Biomarkers, Tumor
  •  go-up   go-down


12. Mesker WE, Vrolijk H, Sloos WC, Tollenaar RA, Tanke HJ: Detection of tumor cells in bone marrow, peripheral blood and lymph nodes by automated imaging devices. Cell Oncol; 2006;28(4):141-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of tumor cells in bone marrow, peripheral blood and lymph nodes by automated imaging devices.
  • The presence of tumor cells in bone marrow, peripheral blood and lymph nodes has proven its clinical and prognostic value.
  • Since the frequency of these cells in bone marrow and blood is sometimes as low as 1 per million and due to the fact that for the analysis of lymph nodes many sectioning levels have to be analyzed, automated imaging devices have been suggested as an useful alternative to conventional manual screening of specimens.
  • [MeSH-major] Bone Marrow / pathology. Diagnostic Imaging / instrumentation. Lymphatic Metastasis / diagnosis. Neoplasm Metastasis / diagnosis. Neoplastic Cells, Circulating
  • [MeSH-minor] Humans. Lymph Nodes / cytology. Lymph Nodes / pathology. Neoplasms / blood. Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16988469.001).
  • [ISSN] 1570-5870
  • [Journal-full-title] Cellular oncology : the official journal of the International Society for Cellular Oncology
  • [ISO-abbreviation] Cell. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 55
  • [Other-IDs] NLM/ PMC4615155
  •  go-up   go-down


13. Santos TC, Marques AP, Höring B, Martins AR, Tuzlakoglu K, Castro AG, van Griensven M, Reis RL: In vivo short-term and long-term host reaction to starch-based scaffolds. Acta Biomater; 2010 Nov;6(11):4314-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After each time period, the scaffolds, surrounding tissue and nearby lymph nodes were explanted, and used for histological analysis and molecular biology evaluation.
  • Nonetheless, comparing the two models, the IM implantation resulted in a slightly higher inflammatory response than the SC implantation with early activation of the lymph nodes.
  • [MeSH-minor] Animals. Electrophoresis, Agar Gel. Gene Expression Regulation / drug effects. Lymph Nodes / drug effects. Lymph Nodes / pathology. Male. Muscles / drug effects. Muscles / pathology. Prosthesis Implantation. Rats. Rats, Sprague-Dawley. Subcutaneous Tissue / drug effects. Subcutaneous Tissue / pathology. Time Factors. Tissue Engineering

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20601228.001).
  • [ISSN] 1878-7568
  • [Journal-full-title] Acta biomaterialia
  • [ISO-abbreviation] Acta Biomater
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 9005-25-8 / Starch
  •  go-up   go-down


14. Chew MH, Chan G, Siddiqui MM, Tai BC, Sivanandan R, Soo KC, Lim DT: Risk-stratified management of well-differentiated thyroid cancers: a review of experience from a single institution, 1990-2003. World J Surg; 2008 Mar;32(3):386-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Surgical resection was performed, and patients with clinically palpable lymph nodes were subjected to radical neck dissection.
  • For those with lymph nodes (50%), 95% had PTC.

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 1992 Sep;75(3):714-20 [1517360.001]
  • [Cites] Cancer. 1998 Jan 15;82(2):375-88 [9445196.001]
  • [Cites] Endocr Pract. 2001 May-Jun;7(3):202-20 [11430305.001]
  • [Cites] Singapore Med J. 2002 Sep;43(9):457-62 [12568423.001]
  • [Cites] Am J Med. 1994 Nov;97(5):418-28 [7977430.001]
  • [Cites] Eur J Cancer. 1979 Aug;15(8):1033-41 [510341.001]
  • [Cites] Endocrinol Metab Clin North Am. 1995 Dec;24(4):803-39 [8608780.001]
  • [Cites] Cancer. 1998 Sep 1;83(5):844-7 [9731884.001]
  • [Cites] J Nucl Med. 1995 Jan;36(1):21-7 [7799075.001]
  • [Cites] Surgery. 2004 Sep;136(3):609-16 [15349109.001]
  • [Cites] Eur J Surg Oncol. 1993 Oct;19(5):399-404 [8405474.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2000;12 (6):373-91 [11202091.001]
  • [Cites] Surgery. 1987 Dec;102(6):1088-95 [3686348.001]
  • [Cites] World J Surg. 1997 Jun;21(5):546-51; discussion 551-2 [9204746.001]
  • [Cites] Oncology. 1994 Jul-Aug;51(4):372-9 [8208524.001]
  • [Cites] Cancer. 1985 May 1;55(9 Suppl):2062-71 [3919920.001]
  • [Cites] Surgery. 1992 Dec;112(6):1139-46; discussion 1146-7 [1455316.001]
  • [Cites] Surgery. 1988 Dec;104(6):954-62 [3194847.001]
  • [Cites] Eur J Cancer. 1994;30A(6):733-9 [7917529.001]
  • [Cites] J Surg Oncol. 2006 Dec 15;94(8):678-82 [17131414.001]
  • [Cites] Cancer. 2002 Aug 1;95(3):488-98 [12209740.001]
  • [Cites] Clin Endocrinol (Oxf). 2005 Oct;63(4):418-27 [16181234.001]
  • [Cites] Trans Am Clin Climatol Assoc. 2002;113:241-60 [12053713.001]
  • [Cites] Cancer. 1996 Jan 1;77(1):172-80 [8630926.001]
  • [Cites] Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8 [8256208.001]
  • [Cites] Ann Surg Oncol. 1997 Jun;4(4):328-33 [9181233.001]
  • [Cites] Cancer. 1986 Oct 15;58(8):1749-55 [3756796.001]
  • [Cites] Surgery. 1994 Dec;116(6):1036-40; discussion 1040-1 [7985084.001]
  • [Cites] Surgery. 1988 Dec;104(6):947-53 [3194846.001]
  • [Cites] Br J Radiol. 1986 Jan;59(697):45-51 [3947807.001]
  • [Cites] Cancer. 1990 Apr 1;65(7):1517-20 [2311063.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2003 Sep;15(6):329-36 [14524486.001]
  • [Cites] J Surg Oncol. 1994 Dec;57(4):252-9; discussion 259-60 [7990481.001]
  • [Cites] Am J Surg. 1992 Dec;164(6):578-81 [1463103.001]
  • [Cites] Ann Surg. 2003 Mar;237(3):399-407 [12616125.001]
  • [Cites] Am Surg. 1993 Mar;59(3):172-6; discussion 176-7 [8476156.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):784-95 [11849802.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1103-9 [15490070.001]
  • (PMID = 18188642.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Tao L, Lefèvre M, Callard P, Périé S, Bernaudin JF, St Guily JL: Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg; 2006 Sep;135(3):445-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
  • OBJECTIVE: To analyze the lymphatic distribution of metastatic carcinomatous cells in cervical lymph nodes in head and neck squamous cell carcinoma (HNSCC).
  • The 4000 lymph nodes were analyzed by optical microscopy using hematoxylin-eosin-safran (HES) staining.
  • RESULTS: Metastases were visualized using HES in 6.4% of lymph nodes for oral cavity, and 4.7% of oropharyngeal, 4.4% of hypopharyngeal, and 1.3% of endolaryngeal cancers.
  • In eight patients (6.7%) with lymph node metastases, level II was spared.
  • In these patients, all 134 nodes histologically negative on HES were confirmed to be negative by IHC.
  • In these cases, level II did not represent the first step of drainage from the tumor.
  • The sentinel lymph node technique in HNSCC is discussed in light of these results.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Coloring Agents. Female. Fluorescent Dyes. Humans. Keratins / analysis. Laryngeal Neoplasms / pathology. Lymph Nodes / pathology. Male. Middle Aged. Mouth Neoplasms / pathology. Neck. Neck Dissection. Neoplasm Staging. Pharyngeal Neoplasms / pathology. Prospective Studies. Retrospective Studies. Sentinel Lymph Node Biopsy

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16949980.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Fluorescent Dyes; 68238-35-7 / Keratins
  •  go-up   go-down


16. Stabel JR, Palmer MV, Harris B, Plattner B, Hostetter J, Robbe-Austerman S: Pathogenesis of Mycobacterium avium subsp. paratuberculosis in neonatal calves after oral or intraperitoneal experimental infection. Vet Microbiol; 2009 May 12;136(3-4):306-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The current study compared the effectiveness of oral and intraperitoneal (IP) methods of experimental inoculation and two strains of M. avium subsp. paratuberculosis (strain K-10 and clinical isolate 509) on the level of infection and lesion development.
  • Fecal shedding of M. avium subsp. paratuberculosis was minimal and infrequent over the course of the study for calves that received strain K-10 (oral and IP), however, calves orally inoculated with the clinical isolate shed high numbers of bacteria in their feces up to 4 months post-inoculation.
  • Colonization was present in a number of intestinal tissues and lymph nodes with the lowest number of affected tissues in the IP calves and the highest for calves receiving the clinical isolate via oral inoculation.
  • Microscopic lesions were predominantly found in the ileal and jejunal sections of small intestine and their associated lymph nodes, as well as the ileocecal valve and node.
  • These data suggest that a variety of experimental infection regimes can be effective but oral inoculation with a clinical isolate may result in greater colonization of tissues and fecal shedding of M. avium subsp. paratuberculosis.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19135813.001).
  • [ISSN] 0378-1135
  • [Journal-full-title] Veterinary microbiology
  • [ISO-abbreviation] Vet. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA, Bacterial; 7S5I7G3JQL / Dexamethasone
  •  go-up   go-down


17. Bader AA, Winter R, Haas J, Tamussino KF: Where to look for the sentinel lymph node in cervical cancer. Am J Obstet Gynecol; 2007 Dec;197(6):678.e1-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Where to look for the sentinel lymph node in cervical cancer.
  • OBJECTIVE: The aim of this study was to analyze lymphatic spread to pelvic, parametrial, and paraaortic lymph nodes in patients with cervical cancer.
  • The present study included 61 patients with one positive lymph node (10%) and 59 patients with two positive lymph nodes (10%) at any location.
  • RESULTS: The external iliac (43%) and obturator (26%) regions and the parametrium (21%) were the most commonly involved pelvic lymph node sites with solitary metastases.
  • Isolated metastases to common iliac, presacral (internal iliac), and paraaortic nodes were found in 7%, 1%, and 1% of patients, respectively.
  • Patients with 2 positive nodes had 1 parametrial and 1 pelvic node involved (32%), 2 ipsilateral positive nodes (31%), 1 positive lymph node on both sides of the pelvis (27%), and 2 positive nodes within the parametrium (10%).
  • CONCLUSIONS: In cervical cancer patients with only 1 positive lymph node, this node is most frequently located within the external iliac and obturator regions and the parametrium.
  • Sentinel node identification should primarily address these lymph node sites.
  • If 1 positive lymph node is found, further metastases are unpredictable within pelvic and parametrial lymph node sites.
  • Paraaortic spread without pelvic node involvement is rare.
  • [MeSH-major] Sentinel Lymph Node Biopsy. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Gynecologic Surgical Procedures. Humans. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Neoplasm Staging


18. Yonemura Y, Endo Y, Hayashi I, Kawamura T, Yun HY, Bandou E: Proliferative activity of micrometastases in the lymph nodes of patients with gastric cancer. Br J Surg; 2007 Jun;94(6):731-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proliferative activity of micrometastases in the lymph nodes of patients with gastric cancer.
  • Sections of lymph nodes were stained by double-immunostaining methods using anti-cytokeratin and anti-Ki-67 antibody (MIB-1).
  • RESULTS: ITCs were detected in 77 nodes from 37 patients, designated as having pN0(i+) lesions.
  • Seventy of 77 lymph nodes with ITCs were detected in the N1 station, and seven were found in the N2 station.
  • CONCLUSION: ITCs have a high proliferative activity and may have the potential to evolve into established lymph node metastasis.
  • [MeSH-major] Lymph Nodes / pathology. Lymphatic Metastasis / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Cell Proliferation. Female. Humans. Immunohistochemistry. Keratins / metabolism. Ki-67 Antigen / metabolism. Male. Prognosis. Sentinel Lymph Node Biopsy. Survival Analysis

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 British Journal of Surgery Society Ltd.
  • (PMID = 17377930.001).
  • [ISSN] 0007-1323
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 68238-35-7 / Keratins
  •  go-up   go-down


19. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, Lim SB, Lee TG, Kim DY, Kim JS, Chang HJ, Lee HS, Kim SY, Jung KH, Hong YS, Kim JH, Sohn DK, Kim DH, Oh JH: Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol; 2010 Jul;11(7):637-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Short-term outcomes assessed were involvement of the circumferential resection margin, macroscopic quality of the total mesorectal excision specimen, number of harvested lymph nodes, recovery of bowel function, perioperative morbidity, postoperative pain, and quality of life.
  • Involvement of the circumferential resection margin, macroscopic quality of the total mesorectal excision specimen, number of harvested lymph nodes, and perioperative morbidity did not differ between the two groups.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Elsevier Ltd. All rights reserved.
  • [CommentIn] Nat Rev Clin Oncol. 2010 Sep;7(9):484 [20824905.001]
  • [CommentIn] Lancet Oncol. 2010 Oct;11(10):919-20; author reply 920-1 [20932489.001]
  • [CommentIn] Lancet Oncol. 2010 Oct;11(10):918-9; author reply 920-1 [20932488.001]
  • [CommentIn] Lancet Oncol. 2010 Jul;11(7):606-7 [20610318.001]
  • (PMID = 20610322.001).
  • [ISSN] 1474-5488
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00470951
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


20. Faroudi M, Hons M, Zachacz A, Dumont C, Lyck R, Stein JV, Tybulewicz VL: Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood; 2010 Dec 16;116(25):5536-47
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Critical roles for Rac GTPases in T-cell migration to and within lymph nodes.
  • Rac-deficient T cells home very inefficiently to lymph nodes and the white pulp of the spleen, show reduced interstitial migration within lymph node parenchyma, and are defective in egress from lymph nodes.
  • [MeSH-major] Cell Movement / physiology. Lymph Nodes / cytology. Neuropeptides / physiology. T-Lymphocytes / cytology. rac GTP-Binding Proteins / physiology


21. Yang CS, Wen MC, Jan YJ, Wang J, Wu CC: Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver. J Chin Med Assoc; 2009 Aug;72(8):430-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The patient underwent segmental resection of the liver and regional lymph node dissection for a tumor mass that measured 7.5 cm in diameter in the right lobe, with regional lymphadenopathy.
  • Histologically, the hepatic tumor was composed of predominantly small-cell NEC, but admixed with a small island of moderately differentiated HCC.
  • We speculate that the NEC originated from a poorly differentiated tumor clone of an HCC that underwent neuroendocrine differentiation, and that this tumor was now at the end stage of the transitional period from HCC to NEC, based on the small amount of disappearing HCC.
  • Ki-67 and p53 expression were higher in the NEC than in the HCC, and the lymph nodes showed only metastatic NEC.
  • Therefore, this kind of tumor had a more aggressive clinical course in accordance with being an NEC rather than a conventional HCC.
  • Three months after operation, the patient had multiple recurrent tumor nodules within the liver, spreading the metastasis to the adrenal glands and para-aortic lymph nodes.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19686999.001).
  • [ISSN] 1728-7731
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 0 / Antigens, CD56; 0 / Ki-67 Antigen
  •  go-up   go-down


22. Sun JY, Ning LS: [Axillary skip metastases in breast cancer]. Zhonghua Zhong Liu Za Zhi; 2008 May;30(5):352-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The clinical data of 1502 breast cancer patients who underwent complete axillary lymph node dissection were retrospectively reviewed.
  • RESULTS: Of the 1502 patients, lymph node metastases were found in 814, of whom skip metastases in 119 (14.6%, 119/814).
  • The Clinicopathologic factors such as age, tumor size, tumor location, clinical stage, hormonal receptor status and involved interpectoral lymph nodes were not correlated with skip metastases (P > 0.05).
  • Multivariate analysis showed that the tumor size, number of metastatic lymph nodes, extracapsular invasion of the lymph nodes and skip metastases in the axilla were significantly correlated with survival rate.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Ductal, Breast / pathology. Lymph Nodes / pathology. Lymphatic Metastasis / pathology
  • [MeSH-minor] Adult. Aged. Axilla. Female. Follow-Up Studies. Humans. Lymph Node Excision. Middle Aged. Neoplasm Staging. Proportional Hazards Models. Retrospective Studies. Survival Rate. Tumor Burden. Young Adult

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18953834.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


23. Zhi XY, Liu BD, Xu QS, Zhang Y, Su L, Wang HR, Hu M: [Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer]. Zhonghua Yi Xue Za Zhi; 2005 Aug 3;85(29):2026-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer].
  • OBJECTIVE: To compare the clinical values of computed tomography (CT) and fluorine-18 fluorodeoxyglucose positron remission tomography (FDG-PET) in diagnosis of mediastinal metastasis of non-small cell lung cancer (NSCLC).
  • METHODS: Sixty patients with respectable NSCLC underwent CT and FDG-PET with an interval of 2 weeks and then underwent thoracotomy for clearance of the lymph nodes or biopsy of the mediastinal lymph nodes via mediastinoscopy.
  • The specimens of mediastinal lymph node underwent HE staining and PCNA/Ki67 immunohistochemical staining.
  • The sensitivity, specificity, accuracy, positive prediction value, and negative prediction value in diagnosis of metastasis of mediastinal lymph nodes of these 2 procedures were compared.
  • RESULTS: The sensitivity, specificity, accuracy, positive prediction value, and negative prediction value in diagnosis of metastasis of mediastinal lymph nodes were 92.3%, 87.5%, 91.2%, 96.0%, and 77.7% respectively for FDG-PET, and were 76.9%, 50.0%, 70.6%, 83.3%, and 40.0% respectively for CT.
  • CONCLUSION: PET is superior to CT in diagnosis of metastasis of NSCLC to mediastinal lymph nodes.
  • PET + CT significantly increases the sensitivity in diagnosis.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / diagnosis. Fluorodeoxyglucose F18. Lung Neoplasms / diagnosis. Lymph Nodes / pathology. Positron-Emission Tomography. Tomography, X-Ray Computed


24. Marrache F, Cazals-Hatem D, Kianmanesh R, Palazzo L, Couvelard A, O'Toole D, Maire F, Hammel P, Levy P, Sauvanet A, Ruszniewski P: Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association? Pancreas; 2005 Jul;31(1):79-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: a fortuitous association?
  • RESULTS: Preoperative diagnosis was unspecified pancreatic tumor (n = 1), IPMN (n = 2), and association of PET and IPMN (n = 3).
  • IPMN involved the main pancreatic duct in 4 patients and was classified as benign (n = 4), borderline (n = 1), or malignant noninvasive (n = 1).
  • PETs measured 1.1 to 3 cm and were malignant in 1 patient (lymph node invasion).
  • CONCLUSION: This study describes a new aspect of endocrine-exocrine pancreatic neoplasm association.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. GLUCAGON .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15968252.001).
  • [ISSN] 1536-4828
  • [Journal-full-title] Pancreas
  • [ISO-abbreviation] Pancreas
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromogranin A; 0 / Chromogranins; 9007-92-5 / Glucagon
  •  go-up   go-down


25. Ahmad Z, Nisa A, Idrees R, Minhas K, Pervez S, Mumtaz K: Hepatic angiosarcoma with metastasis to small intestine. J Coll Physicians Surg Pak; 2008 Jan;18(1):50-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Metastases mainly occur in lymph nodes, spleen, lungs, bones and adrenals.

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18452671.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


26. Shimizu N, Okamoto H, Koyama S, Yane K, Hosoi H, Okamura R: Laryngeal carcinoma in a non-smoker female patient with thyroid carcinoma: report of a case. Auris Nasus Larynx; 2008 Dec;35(4):572-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The case suggests the importance of meticulous examination in the head and neck region for treatment of cervical metastatic lymph nodes with negative cytology in non-smoker female.
  • [MeSH-major] Carcinoma, Papillary / diagnosis. Carcinoma, Squamous Cell / diagnosis. Cell Transformation, Neoplastic / pathology. Laryngeal Neoplasms / diagnosis. Neoplasms, Multiple Primary / diagnosis. Papilloma / diagnosis. Thyroid Neoplasms / diagnosis
  • [MeSH-minor] Combined Modality Therapy. Female. Humans. Larynx / pathology. Lymph Nodes / pathology. Lymphatic Metastasis / pathology. Middle Aged. Neck Dissection. Neoplasm Staging. Radiotherapy, Adjuvant. Smoking / adverse effects. Thyroid Gland / pathology. Thyroidectomy

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18272310.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


27. Kuwamura M, Ide M, Yamate J, Shiraishi Y, Kotani T: Systemic candidiasis in a dog, developing spondylitis. J Vet Med Sci; 2006 Oct;68(10):1117-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Similar granulomatous lesions were observed in the systemic lymph nodes, kidneys, pancreas, spleen, prostate gland, thyroid glands and heart.

  • MedlinePlus Health Information. consumer health - Yeast Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17085895.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


28. Protzel C, Alcaraz A, Horenblas S, Pizzocaro G, Zlotta A, Hakenberg OW: Lymphadenectomy in the surgical management of penile cancer. Eur Urol; 2009 May;55(5):1075-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Several attempts have been made to develop strategies which can improve the diagnostic quality and reduce the morbidity of the management of inguinal lymph nodes in penile cancer.
  • OBJECTIVE: To analyse the existing published data on the surgical management of inguinal nodes in penile cancer regarding morbidity and survival.
  • EVIDENCE ACQUISITION: A Medline search was performed of the English-language literature (1966-September 2008) using the MeSH terms penile carcinoma, lymph node dissection, lymphadenectomy, and complications.
  • EVIDENCE SYNTHESIS: Lymph node metastases are frequent in penile cancer, even in early pT1G2 stages.
  • Since the results of systemic treatment of advanced penile cancer are disappointing, complete dissection of all involved lymph nodes is highly recommended.
  • The extent of lymph node dissection should be adapted to clinical stage, as this corresponds to metastatic spread.
  • For low-risk patients (pTis, pTa, and pT1G1) without palpable lymph nodes and with good compliance, a surveillance strategy may be chosen.
  • For all other patients without palpable lymph nodes (including intermediate risk pT1G2 disease), a modified bilateral lymphadenectomy is recommended.
  • An alternative to this is a dynamic sentinel lymph node biopsy in specialised centres.
  • All patients with histologically proven lymph node metastases should undergo radical inguinal lymphadenectomy.
  • Pelvic lymph node dissection should be done in all patients with more than two metastatic inguinal lymph nodes.
  • In case of fixed inguinal lymph nodes, neoadjuvant chemotherapy is recommended, followed by node resection.
  • CONCLUSIONS: Lymphadenectomy is an integral part of the management of penile cancer, since early dissection of involved lymph nodes improves survival.
  • [MeSH-major] Lymph Node Excision / methods. Lymph Nodes / pathology. Neoplasm Recurrence, Local / pathology. Penile Neoplasms / pathology. Penile Neoplasms / surgery
  • [MeSH-minor] Disease-Free Survival. Humans. Inguinal Canal. Lymphatic Metastasis / prevention & control. Male. Neoplasm Invasiveness / pathology. Neoplasm Staging. Prognosis. Risk Assessment. Survival Analysis

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19264390.001).
  • [ISSN] 1873-7560
  • [Journal-full-title] European urology
  • [ISO-abbreviation] Eur. Urol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 93
  •  go-up   go-down


29. Matsushita S, Kawai K, Tada K, Mera K, Kubo H, Ibusuki A, Yoshii N, Kanekura T: Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy. J Dermatol; 2010 Jul;37(7):666-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary cutaneous squamous cell carcinoma (SCC) is a malignant tumor that arises from keratinizing cells of the epidermis or its appendages.
  • We present a patient with cutaneous SCC on the left instep with metastases to multiple lymph nodes in the para-aortic, iliac and groin region.

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20629834.001).
  • [ISSN] 1346-8138
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


30. Milman N, Sørensen TB: [Treatment of severe sarcoidosis using TNF-alpha-inhibitor (infliximab)]. Ugeskr Laeger; 2006 Jan 30;168(5):484-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We describe a 29-year-old man with histologically verified sarcoidosis and persistent, pronounced enlargement of the peripheral lymph nodes, resistant to treatment with prednisolone and methotrexate.
  • Following treatment with TNF-alpha-inhibitor (infliximab 3 mg/kg body weight), the lymph nodes regressed to normal size and the patient improved clinically.

  • Genetic Alliance. consumer health - Sarcoidosis.
  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • MedlinePlus Health Information. consumer health - Sarcoidosis.
  • Hazardous Substances Data Bank. Infliximab .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16472440.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; B72HH48FLU / Infliximab
  •  go-up   go-down


31. Cassarino DS, Miller WJ, Auerbach A, Yang A, Sherry R, Duray PH: The effects of gp100 and tyrosinase peptide vaccinations on nevi in melanoma patients. J Cutan Pathol; 2006 May;33(5):335-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All had a cutaneous melanoma measuring at least 1.5 mm in depth, satellite metastases, or at least one positive lymph node.
  • Nevi were studied in order to assess the effects on benign melanocytes.
  • The increase in p53 and bcl-2 raises the possibility that vaccination with melanocytic antigens stimulates a response in benign melanocytes.
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Female. HLA Antigens / drug effects. Humans. Immunohistochemistry. Ki-67 Antigen / drug effects. Ki-67 Antigen / metabolism. Male. Middle Aged. Neoplasm Recurrence, Local / prevention & control. Proto-Oncogene Proteins c-bcl-2 / drug effects. Proto-Oncogene Proteins c-bcl-2 / metabolism. T-Lymphocytes / drug effects. T-Lymphocytes / immunology. Tumor Suppressor Protein p53 / drug effects. Tumor Suppressor Protein p53 / metabolism. gp100 Melanoma Antigen

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16640539.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cancer Vaccines; 0 / HLA Antigens; 0 / Ki-67 Antigen; 0 / Membrane Glycoproteins; 0 / PMEL protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Tumor Suppressor Protein p53; 0 / gp100 Melanoma Antigen; EC 1.14.18.1 / Monophenol Monooxygenase
  •  go-up   go-down


32. Harp JR, Gilchrist MA, Onami TM: Memory T cells are enriched in lymph nodes of selectin-ligand-deficient mice. J Immunol; 2010 Nov 15;185(10):5751-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Memory T cells are enriched in lymph nodes of selectin-ligand-deficient mice.
  • Fucosyltransferase-IV and -VII double knockout (FtDKO) mice reveal profound impairment in T cell trafficking to lymph nodes (LNs) due to an inability to synthesize selectin ligands.
  • [MeSH-major] CD8-Positive T-Lymphocytes / cytology. Chemotaxis, Leukocyte / immunology. Immunologic Memory. Lymph Nodes / cytology. Selectins / immunology. T-Lymphocyte Subsets / cytology

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20937846.001).
  • [ISSN] 1550-6606
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI05771901
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Cd44 protein, mouse; 0 / Ligands; 0 / Selectins; EC 2.4.1.- / Fucosyltransferases; EC 2.4.1.- / Fut4 protein, mouse; EC 2.4.1.- / fucosyltransferase VII, mouse
  •  go-up   go-down


33. Kelty CJ, Kennedy CW, Falk GL: Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol; 2010 Sep;5(9):1467-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma.
  • INTRODUCTION: The role of the number of metastatic nodes in esophageal cancer surgery is of interest.
  • RESULTS: Of 224 patients, 148 patients (66%) had adenocarcinoma, 70 (31%) squamous cell carcinoma, and 6 (2.6%) were other tumor types.
  • The total number of affected nodes significantly reduced survival (four or more metastatic nodes).
  • Further analysis of the ratio of nodes affected to the total number resected showed a significant decrease in survival as the percentage of positive nodes increased (p < 0.001).
  • CONCLUSIONS: Patients undergoing surgery for esophageal cancer should be staged according to a minimum total number of metastatic lymph nodes and ratios because this more accurately predicts survival than current staging systems.
  • [MeSH-major] Adenocarcinoma / mortality. Carcinoma, Squamous Cell / mortality. Esophageal Neoplasms / mortality. Esophagectomy. Lymph Node Excision. Lymph Nodes / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Prognosis. Prospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20812404.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A: MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol; 2009 Oct;219(2):214-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To seek a specific miRNA expression signature characterizing the metastatic phenotype of solid tumours, we performed a miRNA microarray analysis on 43 paired primary tumours (ten colon, ten bladder, 13 breast, and ten lung cancers) and one of their related metastatic lymph nodes.
  • To further support our data, we performed an immunohistochemical analysis for three well-defined miRNA gene targets (PDCD4, DHFR, and HOXD10 genes) on a small series of paired colon, breast, and bladder cancers, and one of their metastatic lymph nodes.
  • [MeSH-major] Lymphatic Metastasis / genetics. MicroRNAs / genetics. RNA, Neoplasm / genetics
  • [MeSH-minor] Breast Neoplasms / genetics. Colonic Neoplasms / genetics. Female. Gene Expression Profiling / methods. Gene Expression Regulation, Neoplastic. Genes, Neoplasm. Humans. Lung Neoplasms / genetics. Oligonucleotide Array Sequence Analysis / methods. Reverse Transcriptase Polymerase Chain Reaction / methods. Urinary Bladder Neoplasms / genetics

  • Genetic Alliance. consumer health - Metastatic cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
  • (PMID = 19593777.001).
  • [ISSN] 1096-9896
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / MicroRNAs; 0 / RNA, Neoplasm
  •  go-up   go-down


35. Senda E, Fujimoto K, Ohnishi K, Higashida A, Ashida C, Okutani T, Sakano S, Yamamoto M, Ito R, Yamada H: Minute ampullary carcinoid tumor with lymph node metastases: a case report and review of literature. World J Surg Oncol; 2009;7:9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minute ampullary carcinoid tumor with lymph node metastases: a case report and review of literature.
  • CASE PRESENTATION: We report a case of a 63-year-old woman with a minute ampullary carcinoid tumor that was 7 mm in diameter, but was associated with 2 peripancreatic lymph node metastases.
  • Computed tomography (CT) revealed a markedly dilated common bile duct (CBD) and two enlarged peripancreatic lymph nodes.
  • Endoscopy showed that the ampulla was slightly enlarged by a submucosal tumor.
  • The biopsy specimen revealed tumor cells that showed monotonous proliferation suggestive of a carcinoid tumor.
  • She underwent a pylorus-preserving whipple resection with lymph node dissection.
  • The resected lesion was a small submucosal tumor (7 mm in diameter) at the ampulla, with metastasis to 2 peripancreatic lymph nodes, and it was diagnosed as a malignant carcinoid tumor.
  • However, this case suggests that attention should be paid to the possibility of lymph node metastases as well as that of regional infiltration of the tumor even for minute ampullary carcinoid tumors to provide the best chance for cure.
  • [MeSH-major] Ampulla of Vater. Carcinoid Tumor / secondary. Common Bile Duct Neoplasms / pathology
  • [MeSH-minor] Biopsy. Female. Humans. Lymph Node Excision. Lymph Nodes / pathology. Lymph Nodes / surgery. Lymphatic Metastasis. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Carcinoid Tumor.
  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastrointest Surg. 2008 Apr;12(4):713-7 [17992565.001]
  • [Cites] J Gastrointest Surg. 2003 Sep-Oct;7(6):773-6 [13129555.001]
  • [Cites] Cancer. 1993 Feb 1;71(3):686-90 [8094317.001]
  • [Cites] Cancer. 1994 Mar 15;73(6):1580-8 [8156484.001]
  • [Cites] Korean J Intern Med. 2004 Dec;19(4):257-60 [15683115.001]
  • [Cites] J Gastroenterol Hepatol. 2005 May;20(5):676-81 [15853978.001]
  • [Cites] World J Gastroenterol. 2007 Feb 28;13(8):1268-70 [17451212.001]
  • [Cites] J Clin Gastroenterol. 2007 Aug;41(7):661-6 [17667049.001]
  • [Cites] Endoscopy. 2000 Jul;32(7):S42 [10917194.001]
  • [Cites] J Gastrointest Surg. 2007 Oct;11(10):1322-7 [17674113.001]
  • (PMID = 19159493.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2636813
  •  go-up   go-down


36. Ishiguro T, Kimura H, Araya T, Minato H, Katayama N, Yasui M, Kasahara K, Fujimura M: Eosinophilic pneumonia and thoracic metastases as an initial manifestation of prostatic carcinoma. Intern Med; 2008;47(15):1419-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Positron emission tomography (PET) using (18)F-fluorodeoxyglucose (FDG) showed poor uptake in these nodules and lymph nodes.
  • Based on the morphological and immunohistochemical findings, the nodules in the lung and the lymph nodes were diagnosed as secondary neoplasm from the prostate.
  • Eosinophilic pneumonia in this case disappeared and has not recurred by treatment of prostatic carcinoma and steroid therapy for a week, and was regarded to be tumor-associated.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / pathology. Pulmonary Eosinophilia / diagnosis. Thoracic Neoplasms / diagnosis. Thoracic Neoplasms / secondary

  • Genetic Alliance. consumer health - Pneumonia, eosinophilic.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18670149.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


37. van Vliet EP, van der Lugt A, Kuipers EJ, Tilanus HW, van der Gaast A, Hermans JJ, Siersema PD: Ultrasound, computed tomography, or the combination for the detection of supraclavicular lymph nodes in patients with esophageal or gastric cardia cancer: a comparative study. J Surg Oncol; 2007 Sep 1;96(3):200-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ultrasound, computed tomography, or the combination for the detection of supraclavicular lymph nodes in patients with esophageal or gastric cardia cancer: a comparative study.
  • BACKGROUND AND OBJECTIVES: Both ultrasound (US) and computed tomography (CT) can be used to detect supraclavicular lymph node metastases.
  • Gold standard was postoperative detection of lymph nodes in the resected specimen, FNA, or a radiological result with follow-up.
  • In 4/65 (6%) patients with true-positive malignant lymph nodes, CT was positive with US and/or US-FNA being negative.
  • CONCLUSION: US-FNA seems the preferred diagnostic modality for the detection of supraclavicular lymph node metastases in patients with esophageal or gastric cardia cancer.
  • [MeSH-major] Esophageal Neoplasms / pathology. Lymph Nodes / pathology. Stomach Neoplasms / pathology

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • [CommentIn] J Surg Oncol. 2007 Sep 1;96(3):192-3 [17674366.001]
  • (PMID = 17455243.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


38. Khinkova N, Gorchev G, Tsvetkov Ch, Tomov S: [Sentinel lymph dissection in cervical cancer--prognostic factors]. Akush Ginekol (Sofiia); 2005;44(4):13-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Sentinel lymph dissection in cervical cancer--prognostic factors].
  • INTRODUCTION: The concept for the sentinel lymph nodes is one of the most significant and interesting achievements in clinical oncology in the last 10 years.
  • It is possible according to it, by dissection and studing of one or a small number of lymph nodes, the status of the regional lymphatic network drainage to be foreseen.
  • OBJECTIVE: To study the application of sentinel lymph nodes detection by applying Patent blue V marker in patients with invasive cervical cancer who had undergone radical hysterectomy and pelvic and/or paraaortic lymph detection.
  • MATERIAL AND METHODS: In a prospective study in the period from January 2001- December 2003 the mapping technique for detection of the sentinel lymph nodes was utilized in 129 patients with cervical cancer.
  • Intraoperativly it was looked for blue coloured lymph flows going to the first (sentinel) lymph nodes in the pelvic lymphatic network drainage and the paraaortic area.
  • All patients had a radical surgical intervention on the uterus and the lymph nodes but in a different degree.
  • CONCLUSIONS: The mapping method of detection of the sentinel lymph nodes could be utilized for patients with early stage of cervical cancer.
  • [MeSH-major] Lymph Nodes / pathology. Sentinel Lymph Node Biopsy / methods. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Coloring Agents. Female. Humans. Hysterectomy. Lymphatic Metastasis. Middle Aged. Neoplasm Invasiveness. Prognosis. Prospective Studies. Rosaniline Dyes. Staining and Labeling


39. Bembenek A, Li J, Loddenkemper C, Kemmner W, Stein H, Wernecke KD, Schlag PM: Presence of mature DC-Lamp+ dendritic cells in sentinel and non-sentinel lymph nodes of breast cancer patients. Eur J Surg Oncol; 2008 May;34(5):514-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Presence of mature DC-Lamp+ dendritic cells in sentinel and non-sentinel lymph nodes of breast cancer patients.
  • PATIENTS AND METHODS: Paraffin blocks of the SLN and non-SLN from patients with primary breast cancer who had undergone SLN biopsy and axillary dissection were separated into three groups: (Group A) no tumor cell involvement in the SLN and non-SLN; (Group B) isolated tumor cells or micrometastases in the SLN, and tumor cell-free non-SLN; and (Group C) macrometastases in the SLN.
  • [MeSH-major] Breast Neoplasms / pathology. Dendritic Cells / immunology. Lymph Nodes / pathology
  • [MeSH-minor] Biopsy, Fine-Needle. Female. Humans. Lysosome-Associated Membrane Glycoproteins / immunology. Sentinel Lymph Node Biopsy

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17618075.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Lysosome-Associated Membrane Glycoproteins
  •  go-up   go-down


40. Dzwierzynski WW: Complete lymph node dissection for regional nodal metastasis. Clin Plast Surg; 2010 Jan;37(1):113-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complete lymph node dissection for regional nodal metastasis.
  • The primary management of lymph nodes involved with metastatic melanoma is regional lymphadenectomy.
  • Axillary or inguinal node complete lymph node dissection (CLND) is performed after an occult metastasis is found by sentinel lymph node biopsy, or after a clinically apparent regional lymph node metastasis.
  • CLND completely removes all lymph-node-bearing tissue in a nodal basin.
  • [MeSH-major] Lymph Node Excision / methods. Melanoma / surgery. Skin Neoplasms / pathology
  • [MeSH-minor] Axilla. Groin. Humans. Lymphatic Metastasis. Neoplasm Recurrence, Local. Postoperative Care. Sentinel Lymph Node Biopsy

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19914463.001).
  • [ISSN] 1558-0504
  • [Journal-full-title] Clinics in plastic surgery
  • [ISO-abbreviation] Clin Plast Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 61
  •  go-up   go-down


41. Toplu N, Aydoğan A, Oguzoglu TC: Visceral leishmaniosis and parapoxvirus infection in a Mediterranean monk seal (Monachus monachus). J Comp Pathol; 2007 May;136(4):283-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The pathological findings included a deep ulcer on the side of the head, ulcers on the gingival and inner aspect of the lower lip, enlarged lymph nodes and tonsils, and respiratory lesions (pulmonary consolidation, oedema, haemorrhages and emphysema; tracheal and bronchial congestion, exudates and haemorrhage).
  • Amastigotes were demonstrated in macrophages in the lymph nodes and spleen, and intracytoplasmic inclusion bodies were observed in the tracheal and oral mucosa.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17459405.001).
  • [ISSN] 0021-9975
  • [Journal-full-title] Journal of comparative pathology
  • [ISO-abbreviation] J. Comp. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


42. Saunders GK, Monroe WE: Systemic granulomatous disease and sialometaplasia in a dog with Bartonella infection. Vet Pathol; 2006 May;43(3):391-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Systemic granulomatous disease involving the spleen, heart, lymph nodes, omentum, liver, kidney, lung, mediastinum, and salivary glands developed in an 8-year-old Rottweiler.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16672593.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Eaton M, Fox R: Surgical biopsy in lymphoma. ANZ J Surg; 2005 Sep;75(9):810-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The majority of lymphomas arise from lymph nodes, while some may originate in extranodal sites.

  • MedlinePlus Health Information. consumer health - Biopsy.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16173999.001).
  • [ISSN] 1445-1433
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


44. Hoffer FA: Magnetic resonance imaging of abdominal masses in the pediatric patient. Semin Ultrasound CT MR; 2005 Aug;26(4):212-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Magnetic resonance (MR) plays a unique role in the diagnosis and management of pediatric abdominal masses.
  • Specific advantages of MR include determination of resectability of hepatic tumors using MRI and MRA; staging of neuroblastoma in the bone marrow, lymph nodes, liver, and spinal canal; response of bilateral Wilms tumor and nephroblastomatosis; detection of pelvic tumors with sagittal sectioning, and peritoneal tumors with contrast enhancement.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Kidney Neoplasms / diagnosis. Liver Neoplasms / diagnosis. Magnetic Resonance Imaging / methods. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Child. Diagnosis, Differential. Humans. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16152736.001).
  • [ISSN] 0887-2171
  • [Journal-full-title] Seminars in ultrasound, CT, and MR
  • [ISO-abbreviation] Semin. Ultrasound CT MR
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 21765
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] United States
  • [Number-of-references] 20
  •  go-up   go-down


45. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J: Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol; 2009 Dec;72(3):381-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
  • PURPOSE: To evaluate echo-planar diffusion-weighted MR imaging (DWI) in the differentiation between benign and malignant cervical lymph nodes.
  • MATERIALS AND METHODS: 35 consecutive patients with 55 enlarged (>10mm) cervical lymph nodes underwent MR imaging at 1.5-T.
  • Apparent diffusion coefficient (ADC) maps were reconstructed for all patients and ADC values were calculated for each lymph node.
  • RESULTS: Cervical lymph node enlargement was secondary to metastases from squamous cell carcinomas [n=25], non-Hodgkin's lymphoma [n=6], reactive lymphadenitis [n=20], cat scratch lymphadenitis [n=2] and sarcoidosis [n= 2].
  • The mean ADC values (x10(-3) mm(2)/s) were 0.78+/-0.09 for metastatic lymph nodes, 0.64+/-0.09 for lymphomatous nodes and 1.24+/-0.16 for benign cervical lymph nodes.
  • ADC values of malignant lymph nodes were significantly lower than ADC values of benign lymph nodes.
  • 94.3% of lesions were correctly classified as benign or malignant using a threshold ADC value of 1.02 x 10(-3) mm(2)/s.
  • CONCLUSION: According to our first experience, DWI using a SSEPI sequence allows reliable differentiation between benign and malignant cervical lymph nodes.
  • [MeSH-major] Diffusion Magnetic Resonance Imaging / methods. Head and Neck Neoplasms / diagnosis. Lymph Nodes / pathology. Lymphatic Diseases / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neck / pathology. Reproducibility of Results. Sensitivity and Specificity. Young Adult

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18995981.001).
  • [ISSN] 1872-7727
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


46. Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, Binsky I, Vallon-Eberhard A, Sapoznikov A, Burger M, Shachar I, Haran M, Honczarenko M, Greil R, Alon R: Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Cancer Res; 2009 Apr 1;69(7):3121-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
  • Furthermore, when injected into tail veins of immunodeficient mice, normal B cells rapidly homed to lymph nodes (LN) in a LFA-1-dependent manner, whereas CLL cells did not.
  • [MeSH-major] Bone Marrow / immunology. Cell Movement / immunology. Leukemia, Lymphocytic, Chronic, B-Cell / immunology. Lymph Nodes / immunology. Neoplastic Cells, Circulating / immunology

  • Genetic Alliance. consumer health - Chronic Lymphocytic Leukemia.
  • Genetic Alliance. consumer health - Leukemia, B-cell, chronic.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19293181.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chemokines; 0 / Integrin alpha4beta1; 0 / Lymphocyte Function-Associated Antigen-1
  •  go-up   go-down


47. Lamoreaux WT, Grigsby PW, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA: FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys; 2005 Jul 1;62(3):733-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To compare the results of CT and positron emission tomography (PET) and F-18 fluorodeoxyglucose (FDG) in the detection of the primary tumor and lymph node metastases in carcinoma of the vagina.
  • The tumor was clinical Stage II in 16 patients, Stage III in 6, and Stage IVa in 1 patient.
  • The primary tumor ranged in size from 2 to 10 cm (mean 4.9), and 4 patients had palpable groin lymph nodes.
  • All patients were treated with external beam radiotherapy and brachytherapy, 14 received concurrent chemotherapy, and 2 underwent primary tumor excision before the imaging evaluation.
  • RESULTS: Of the 21 patients with an intact primary tumor, CT visualized it in 9 (43%).
  • CT also demonstrated abnormally enlarged groin lymph nodes in 3 patients and both groin and pelvic lymph nodes in 1 patient (4 of 23, 17%).
  • Abnormal uptake was found in the groin lymph nodes in 4 patients, pelvic lymph nodes in 2, and both groin and pelvic lymph nodes in 2 patients (8 of 23, 35%).
  • CONCLUSION: The results of this study have demonstrated that FDG-PET detects the primary tumor and abnormal lymph nodes more often than does CT.
  • [MeSH-minor] Combined Modality Therapy. Female. Humans. Lymphatic Metastasis / radiography. Lymphatic Metastasis / radionuclide imaging. Neoplasm Staging. Positron-Emission Tomography. Prospective Studies. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15936553.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


48. Liang H, Tang HW, Hao XS, Sun H, Li W: [Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles]. Zhonghua Zhong Liu Za Zhi; 2005 Jul;27(7):412-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MMC bound to activated carbon particles (MMC-CH).
  • RESULTS: The MMC concentration in peritoneal exudate, omentum and lymph nodes of MMC-CH group was significantly higher than that of MMC solution i.p. group and MMC i.v. group (P < 0.001).
  • High MMC level was maintained longer than 24 hours in the MMC-CH group.
  • Intraperitoneal chemotherapy with MMC solution resulted in a low MMC concentration in serum, peritoneal exudates and lymph nodes, and only a transient high level of MMC in the omentum.
  • After i.v. administration, a significantly higher level of MMC concentration occurred in the serum, but only a shortly increased concentration of MMC in the omentum, and lower concentration in peritoneal exudate and lymph nodes as compared with those in the other two groups (P < 0.001).
  • CONCLUSION: High concentration of MMC in peritoneal exudate, omentum and lymph nodes maintained longer than 24 hours and a significantly lower MMC serum concentration can be achieved by administration of intraperitoneal administration of MMC bound to activated carbon particles.
  • [MeSH-minor] Animals. Antibiotics, Antineoplastic / administration & dosage. Antibiotics, Antineoplastic / pharmacokinetics. Female. Humans. Injections, Intraperitoneal. Male. Mice. Mice, Inbred BALB C. Mice, Nude. Neoplasm Transplantation

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. ACTIVATED CHARCOAL .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16188126.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 16291-96-6 / Charcoal; 50SG953SK6 / Mitomycin
  •  go-up   go-down


49. Lobov GI, Pan'kova MN: [NO-dependent. Modulation of contractile function in capsule of lymph nodes]. Ross Fiziol Zh Im I M Sechenova; 2010 May;96(5):489-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [NO-dependent. Modulation of contractile function in capsule of lymph nodes].
  • Phase and tonic contractions of capsular smooth muscles of bovine mesenteric lymph nodes were studied in vitro.
  • Smooth muscle cells of the node capsule demonstrated spontaneous contractile activity; frequency of spontaneous phase contractions was averaged 1.1 +/- 0.14 min(-1), amplitude 1.7 +/- 0.21 mH.
  • Sodium nitroprusside (0.1-1 microM) and acethylcholine (1 microM) reduced frequency and amplitude of phase contractions of smooth muscles of the lymph node, sodium nitroprusside (1 microM) arrested spontaneous contractile activity completely and decreased tone of the smooth muscle cells.
  • We suggest that endothelial cells of subcapsular sinus of the lymph node produce NO which results in opening of ATP-sensitive K(+)-channels of smooth muscle cell membrane by means of cascade reaction and the relaxation of smooth muscle.

  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20583572.001).
  • [ISSN] 0869-8139
  • [Journal-full-title] Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova
  • [ISO-abbreviation] Ross Fiziol Zh Im I M Sechenova
  • [Language] RUS
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Cholinergic Agents; 0 / Enzyme Inhibitors; 0 / Hypoglycemic Agents; 0 / Nitric Oxide Donors; 0 / Potassium Channels; 169D1260KM / Nitroprusside; 31C4KY9ESH / Nitric Oxide; N9YNS0M02X / Acetylcholine; SX6K58TVWC / Glyburide; V55S2QJN2X / NG-Nitroarginine Methyl Ester
  •  go-up   go-down


50. Meier A, Satzger I, Völker B, Kapp A, Gutzmer R: Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center. Cancer; 2010 Jul 1;116(13):3178-88
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center.
  • BACKGROUND: In melanoma, different classification systems have been proposed that predict overall survival (OS) and recurrence-free survival (RFS) based on findings in the sentinel lymph node (SLN).
  • METHODS: The Rotterdam system (based on the greatest dimension of the largest tumor cell deposit), the Augsburg S-classification (based on tumor penetrative depth [TPD]), and the Hannover system (based on a combination of tumor load, TPD, and invasion of the capsule) were studied in 697 consecutive melanoma patients who underwent SLN biopsy at the authors' center.
  • In multivariate analysis using a Cox model, the greatest dimension of the largest tumor cell deposit (cutoff point, <0.1 mm vs > or = 0.1 mm), the TPD (cutoff point, < or = 2 mm vs > 2 mm), and capsular involvement represented independent parameters for RFS; and TPD and capsular involvement also were independent parameters for OS.
  • [MeSH-major] Classification / methods. Melanoma / pathology. Neoplasm Staging / methods. Sentinel Lymph Node Biopsy. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Lymph Nodes / pathology. Lymphatic Metastasis / pathology. Male. Middle Aged. Prognosis. Risk Assessment / methods

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer. 2011 Jun 15;117(12):2821; author reply 2821 [21264822.001]
  • (PMID = 20564647.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


51. Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH: Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest; 2007 Sep;117(9):2570-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
  • A small population of plasmacytoid DCs (pDCs) in mouse tumor-draining LNs can express the immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO).
  • In vivo, Tregs isolated from tumor-draining LNs were constitutively activated and suppressed antigen-specific T cells immediately ex vivo.
  • In vitro, IDO+ pDCs from tumor-draining LNs rapidly activated resting Tregs from non-tumor-bearing hosts without the need for mitogen or exogenous anti-CD3 crosslinking.
  • Tregs isolated from tumor-draining LNs in vivo showed potent PD-1/PD-L-mediated suppression, which was selectively lost when tumors were grown in IDO-deficient hosts.
  • We hypothesize that IDO+ pDCs create a profoundly suppressive microenvironment within tumor-draining LNs via constitutive activation of Tregs.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2007 May;117(5):1147-54 [17476344.001]
  • [Cites] Science. 2002 Sep 13;297(5588):1867-70 [12228717.001]
  • [Cites] Lab Invest. 2003 Oct;83(10):1457-66 [14563947.001]
  • [Cites] Nat Immunol. 2003 Dec;4(12):1206-12 [14578884.001]
  • [Cites] Gastroenterology. 2003 Dec;125(6):1762-73 [14724829.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):1097-101 [12368911.001]
  • [Cites] J Immunol. 2002 Nov 15;169(10):5538-45 [12421930.001]
  • [Cites] J Exp Med. 2003 Feb 17;197(4):403-11 [12591899.001]
  • [Cites] Mol Cell. 2003 Mar;11(3):619-33 [12667446.001]
  • [Cites] Nat Med. 2003 May;9(5):562-7 [12704383.001]
  • [Cites] J Immunol. 2003 Aug 15;171(4):1652-5 [12902462.001]
  • [Cites] Eur J Immunol. 2003 Oct;33(10):2773-82 [14515261.001]
  • [Cites] Eur J Immunol. 2004 Feb;34(2):336-44 [14768038.001]
  • [Cites] Eur J Immunol. 2004 Feb;34(2):366-76 [14768041.001]
  • [Cites] J Immunol. 2004 Apr 1;172(7):4100-10 [15034022.001]
  • [Cites] J Immunol. 2004 Jun 1;172(11):6519-23 [15153463.001]
  • [Cites] J Clin Invest. 2004 Jul;114(2):280-90 [15254595.001]
  • [Cites] Cell. 1994 Jan 14;76(1):17-27 [8287475.001]
  • [Cites] Science. 1994 May 13;264(5161):961-5 [7513904.001]
  • [Cites] Nat Med. 1995 Jul;1(7):649-53 [7585145.001]
  • [Cites] Int Immunol. 1996 May;8(5):765-72 [8671665.001]
  • [Cites] Int Immunol. 1996 Mar;8(3):351-8 [8671621.001]
  • [Cites] J Exp Med. 1998 Jul 20;188(2):287-96 [9670041.001]
  • [Cites] J Immunol. 1998 Aug 15;161(4):1868-74 [9712055.001]
  • [Cites] Science. 1998 Aug 21;281(5380):1191-3 [9712583.001]
  • [Cites] J Exp Med. 1999 May 3;189(9):1363-72 [10224276.001]
  • [Cites] Nat Immunol. 2005 Mar;6(3):280-6 [15685176.001]
  • [Cites] Nat Med. 2005 Mar;11(3):312-9 [15711557.001]
  • [Cites] J Exp Med. 2005 Mar 7;201(5):681-6 [15753203.001]
  • [Cites] Blood. 2005 Apr 1;105(7):2862-8 [15591121.001]
  • [Cites] Immunity. 2005 May;22(5):633-42 [15894280.001]
  • [Cites] Int Immunol. 2005 Jul;17(7):909-19 [15967784.001]
  • [Cites] Biochem Soc Trans. 2006 Feb;34(Pt 1):7-11 [16246168.001]
  • [Cites] Curr Opin Immunol. 2005 Dec;17(6):638-42 [16209918.001]
  • [Cites] Curr Opin Immunol. 2006 Apr;18(2):206-13 [16464564.001]
  • [Cites] Nat Rev Immunol. 2006 Apr;6(4):295-307 [16557261.001]
  • [Cites] Trends Immunol. 2006 Apr;27(4):195-201 [16500147.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64 [16617117.001]
  • [Cites] J Immunol. 2006 Jun 1;176(11):6752-61 [16709834.001]
  • [Cites] J Immunol. 2006 Jul 1;177(1):40-4 [16785496.001]
  • [Cites] Immunol Rev. 2006 Oct;213:146-58 [16972902.001]
  • [Cites] Nat Rev Immunol. 2006 Oct;6(10):715-27 [16977338.001]
  • [Cites] FASEB J. 2006 Nov;20(13):2384-6 [17015408.001]
  • [Cites] Eur J Immunol. 2007 Jan;37(1):129-38 [17154262.001]
  • [Cites] Cancer Res. 2007 Jan 15;67(2):792-801 [17234791.001]
  • [Cites] Nat Immunol. 2007 Mar;8(3):239-45 [17304234.001]
  • [Cites] Blood. 2007 Apr 15;109(8):3351-9 [17158233.001]
  • [Cites] J Immunol. 2000 Jan 1;164(1):183-90 [10605010.001]
  • [Cites] J Exp Med. 2000 Apr 3;191(7):1241-6 [10748241.001]
  • [Cites] Immunity. 2002 Feb;16(2):311-23 [11869690.001]
  • [Cites] Nat Med. 2003 Oct;9(10):1269-74 [14502282.001]
  • (PMID = 17710230.001).
  • [ISSN] 0021-9738
  • [Journal-full-title] The Journal of clinical investigation
  • [ISO-abbreviation] J. Clin. Invest.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD041187; United States / NCI NIH HHS / CA / CA096651; United States / NCI NIH HHS / CA / R01 CA103320; United States / NCI NIH HHS / CA / R01 CA096651; United States / NIAID NIH HHS / AI / AI063402; United States / NCI NIH HHS / CA / CA103320; United States / NICHD NIH HHS / HD / HD41187; United States / NIAID NIH HHS / AI / R01 AI063402; United States / NCI NIH HHS / CA / R01 CA112431; United States / NCI NIH HHS / CA / CA112431
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD274; 0 / Antigens, CD80; 0 / Cd274 protein, mouse; 0 / Histocompatibility Antigens; 0 / Indoleamine-Pyrrole 2,3,-Dioxygenase; 0 / Ligands; 0 / Membrane Glycoproteins; 0 / Peptides
  • [Other-IDs] NLM/ PMC1940240
  •  go-up   go-down


52. Al-Maghrabi J, Kanaan H: Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) in Saudi Arabia: clinicopathology and immunohistochemistry. Ann Saudi Med; 2005 Jul-Aug;25(4):319-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Kikuchi-Fujimoto disease (KFD) is a rare entity of uncertain cause that commonly presents as a benign self-limiting disease of unknown origin.
  • METHODS: We reviewed the histopathological reports of all lymph nodes resected at or referred to King Abdulaziz University Hospital between 1990 and 2003 and King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia between 2000 and 2003.
  • RESULTS: In 2500 lymph node biopsies, 15 cases were diagnosed as KFD.
  • CONCLUSION: The results support earlier findings that KFD is a self-limiting disorder that requires no specific management.
  • Apoptosis-regulating proteins are not helpful in the diagnosis.
  • [MeSH-minor] Adolescent. Adult. Antigens, Differentiation, T-Lymphocyte / metabolism. Apoptosis Regulatory Proteins / metabolism. B-Lymphocytes / metabolism. Biomarkers / metabolism. Female. Histiocytes / metabolism. Humans. Immunohistochemistry. Ki-67 Antigen / metabolism. Male. Middle Aged. Proto-Oncogene Proteins c-bcl-2 / metabolism. Saudi Arabia / epidemiology. Sentinel Lymph Node Biopsy. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Kikuchi disease.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16212126.001).
  • [ISSN] 0256-4947
  • [Journal-full-title] Annals of Saudi medicine
  • [ISO-abbreviation] Ann Saudi Med
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Antigens, Differentiation, T-Lymphocyte; 0 / Apoptosis Regulatory Proteins; 0 / Biomarkers; 0 / Ki-67 Antigen; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


53. Shen CH, Talay O, Mahajan VS, Leskov IB, Eisen HN, Chen J: Antigen-bearing dendritic cells regulate the diverse pattern of memory CD8 T-cell development in different tissues. Proc Natl Acad Sci U S A; 2010 Dec 28;107(52):22587-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that after respiratory tract infection of mice with influenza virus, viral antigen associated with dendritic cells (DCs) was abundant in lung-draining lymph nodes (DLN) and the spleen for more than a week but was scant and transient in nondraining lymph nodes (NDLN).

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol. 2004 Dec 1;173(11):6694-702 [15557161.001]
  • [Cites] Science. 1996 Apr 5;272(5258):54-60 [8600537.001]
  • [Cites] Nat Immunol. 2005 Aug;6(8):793-9 [16025119.001]
  • [Cites] Immunol Rev. 2006 Jun;211:146-53 [16824124.001]
  • [Cites] Immunol Rev. 2006 Jun;211:154-63 [16824125.001]
  • [Cites] J Exp Med. 2006 Sep 4;203(9):2135-43 [16908626.001]
  • [Cites] Science. 2007 Mar 23;315(5819):1687-91 [17332376.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9782-7 [17522251.001]
  • [Cites] J Immunol. 2007 Nov 15;179(10):6704-14 [17982060.001]
  • [Cites] J Immunol. 2007 Nov 15;179(10):6725-33 [17982062.001]
  • [Cites] J Immunol. 2007 Dec 15;179(12):8313-21 [18056376.001]
  • [Cites] J Immunol. 2008 Jan 1;180(1):171-8 [18097017.001]
  • [Cites] J Immunol. 2008 Feb 1;180(3):1309-15 [18209024.001]
  • [Cites] Nature. 1999 Oct 14;401(6754):708-12 [10537110.001]
  • [Cites] J Immunol. 2000 Apr 15;164(8):4063-70 [10754299.001]
  • [Cites] Nat Immunol. 2001 May;2(5):415-22 [11323695.001]
  • [Cites] Nat Immunol. 2001 May;2(5):423-9 [11323696.001]
  • [Cites] J Clin Invest. 2001 Sep;108(6):871-8 [11560956.001]
  • [Cites] J Immunol. 2001 Nov 1;167(9):4838-43 [11673487.001]
  • [Cites] Immunity. 2002 Aug;17(2):211-20 [12196292.001]
  • [Cites] Immunity. 2003 Feb;18(2):265-77 [12594953.001]
  • [Cites] Nat Immunol. 2003 Mar;4(3):225-34 [12563257.001]
  • [Cites] Microbes Infect. 2003 Mar;5(3):233-40 [12681413.001]
  • [Cites] J Exp Med. 1992 Dec 1;176(6):1693-702 [1460426.001]
  • [Cites] Nature. 1994 Jun 23;369(6482):652-4 [7516039.001]
  • [Cites] J Exp Med. 2005 Feb 21;201(4):579-90 [15710650.001]
  • (PMID = 21149737.001).
  • [ISSN] 1091-6490
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI069208; United States / NIGMS NIH HHS / GM / T32 GM007753; United States / NIAID NIH HHS / AI / AI69208
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens; 0 / Antigens, Viral; 0 / Oligopeptides; 0 / Receptors, Antigen, T-Cell; 0 / superagonist SIYR; 82115-62-6 / Interferon-gamma
  • [Other-IDs] NLM/ PMC3012462
  •  go-up   go-down


54. Guillermo de la Mora-Levy J, Romero-Lagarza AP, de Larios NM, López-Acosta ME, Rodríguez-Vanegas G, Farca-Belsaguy A: [Endoscopic ultrasound guided fine needle aspiration biopsy: first experience in Mexico]. Rev Gastroenterol Mex; 2005 Jul-Sep;70(3):253-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The biopsy site, quality of the material obtained, cytological as well as final diagnosis and complications are described.
  • FNA was performed on the pancreas, esophagus, stomach, duodenum, mediastinum, rectum and lymph nodes.
  • A diagnosis was obtained in 75%.
  • In the remaining cases, the material obtained was either inadequate or insufficient for diagnosis.
  • The best results were obtained in lymph nodes, mediastinum, liver and pancreatic tumors.
  • CONCLUSIONS: This study demonstrated the utility of EUS-guided FNA to obtain cytologic material for diagnosis in a high percentage of cases and with minimal complications.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17063780.001).
  • [ISSN] 0375-0906
  • [Journal-full-title] Revista de gastroenterología de México
  • [ISO-abbreviation] Rev Gastroenterol Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


55. Lin WM, Girardi M: More or less: copy number alterations in mycosis fungoides. J Invest Dermatol; 2010 Apr;130(4):926-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MF may vary from limited patchy skin disease to extensive cutaneous plaque and tumor involvement to extracutaneous compartments of blood, lymph nodes, and viscera.

  • Genetic Alliance. consumer health - Mycosis fungoides.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Invest Dermatol. 2010 Apr;130(4):1126-35 [19759554.001]
  • (PMID = 20231832.001).
  • [ISSN] 1523-1747
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Comment; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Genetic Markers
  •  go-up   go-down


56. Osoegawa A, Nosaki K, Miyamoto H, Kometani T, Hirai F, Ondo K, Seto T, Sugio K, Choi YL, Soda M, Mano H, Ichinose Y: Incidentally proven pulmonary "ALKoma". Intern Med; 2010;49(6):603-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 39-year-old woman with multiple brain metastases and bulky mediastinal lymph node metastases was admitted.
  • Biopsy from her supraclavicular lymph nodes was performed to differentiate the diagnosis between lymphoma and lung cancer.
  • Pathologically, the lymph nodes had a feature of adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / genetics. Cell Cycle Proteins / genetics. Chromosome Inversion / genetics. Lung Neoplasms / diagnosis. Lung Neoplasms / genetics. Microtubule-Associated Proteins / genetics. Protein-Tyrosine Kinases / genetics. Serine Endopeptidases / genetics
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Female. Humans. In Situ Hybridization, Fluorescence. Lymph Nodes / pathology. Lymphoma / diagnosis. Lymphoma / pathology. Receptor Protein-Tyrosine Kinases

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20228600.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Microtubule-Associated Proteins; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / anaplastic lymphoma kinase; EC 3.4.21.- / EML4 protein, human; EC 3.4.21.- / Serine Endopeptidases
  •  go-up   go-down


57. Alsayed Y, Leleu X, Leontovich A, Oton AB, Melhem M, George D, Ghobrial IM: Proteomics analysis in post-transplant lymphoproliferative disorders. Eur J Haematol; 2008 Oct;81(4):298-303
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Six tumor samples from adult patients with PTLD and four benign lymph nodes were studied using protein microarray technique.

  • MedlinePlus Health Information. consumer health - Organ Transplantation.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18573174.001).
  • [ISSN] 1600-0609
  • [Journal-full-title] European journal of haematology
  • [ISO-abbreviation] Eur. J. Haematol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / HSP90 Heat-Shock Proteins; 0 / NF-kappa B; EC 2.7.- / Protein Kinases; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.1 / MTOR protein, human; EC 2.7.1.1 / TOR Serine-Threonine Kinases
  •  go-up   go-down


58. Babintsev AV, Fadeev NP, Karelin MI: [Lymphoprostatic scintigraphy in regional lymphatic mapping in patients with prostate cancer]. Vestn Rentgenol Radiol; 2008 Jan-Feb;(1):54-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of the investigation was to upgrade the diagnosis quality for metastatic lesion to the regional lymp nodes in prostate cancer.
  • The results of the most widely used diagnostic techniques (computed tomography (CT), magnetic resonance Imaging, (MRI), radionuclide studies (RNS), and ultrasonography (USG)), which had been compared with those of histology of removed lymph nodes, were assessed.
  • The comparative assessment of radiodiagnostic techniques (USG, CT, MRI, and RNS) showed the high informative value of retroperitoneal lymph nodal MRI in the detection of structural-and-morphological and anatomic-and-topographic changes in the lymph nodes (87.5% sensitivity, 83.3% specificity, and 85.7% accuracy).
  • The developed lymphoprostatic scintigraphy (LPSG) is an informative technique that allows the better diagnosis of prostate metastases to the regional lymph nodes (92.4% sensitivity, 91.7% specificity, and 92.1% accuracy; the prognostic value of a positive result is 90.7%).
  • [MeSH-minor] Algorithms. Humans. Lymphadenitis / etiology. Magnetic Resonance Imaging. Male. Neoplasm Staging. Sensitivity and Specificity. Tomography, X-Ray Computed. Ultrasonography

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22187901.001).
  • [ISSN] 0042-4676
  • [Journal-full-title] Vestnik rentgenologii i radiologii
  • [ISO-abbreviation] Vestn Rentgenol Radiol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


59. Dharan M: Hyaline globules in ectopic decidua in a pregnant woman with cervical squamous cell carcinoma. Diagn Cytopathol; 2009 Sep;37(9):696-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Decidual reaction in pelvic lymph nodes has been increasingly documented during pregnancy.
  • Cytological smears of two of the lymph nodes from intraoperative FS revealed isolated eosinophilic hyaline globules (HG) measuring 45-50 microns, in addition to large polygonal cells with amphophilic cytoplasm and hypochromatic nuclei and occasional squamous-looking cells with atypical hyperchomatic nuclei.
  • These findings posed a diagnostic dilemma at intraoperative consultation and no definitive diagnosis was rendered.
  • The formlin-fixed, paraffin-embedded histological sections of the same lymph nodes showed ectopic decidua with no evidence of metastatic SCC.
  • In pregnant women complicated by cervical cancer intraoperative evaluation of pelvic lymph nodes is of utmost importance in order to adopt the optimal conservative treatment modality.
  • In the absence of clear cut evidence of malignancy, a diagnosis of metastatic SCC should not be rendered.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Choristoma / pathology. Decidua. Lymph Nodes / pathology. Pregnancy Complications, Neoplastic / pathology. Uterine Cervical Neoplasms / pathology


60. Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, Radford JA, Byers RJ: Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood; 2007 May 1;109(9):3922-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We applied real-time polymerase chain reaction (PCR) to polyA cDNAs prepared from 106 archived human frozen lymph nodes (63 of FL, 25 of DLBCL, 10 reactive lymph nodes, and cases with paired samples of FL [4] and subsequent DLBCL [4]).
  • Six genes showed statistically significant higher expression in the neoplastic nodes compared with reactive nodes, namely PRKCB1, BCL-6, EAR2, ZFX, cyclin B, YY1.
  • [MeSH-major] Gene Expression Profiling. Gene Expression Regulation, Leukemic. Lymphoma, B-Cell / metabolism. Lymphoma, Follicular / metabolism. Lymphoma, Large B-Cell, Diffuse / metabolism. Neoplasm Proteins / biosynthesis. Oligonucleotide Array Sequence Analysis


61. Youk JH, Kim EK, Ko KH, Kim MJ: Sonographic features of axillary lymphadenopathy caused by Kikuchi disease. J Ultrasound Med; 2008 Jun;27(6):847-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The medical records and sonographic findings of 7 patients with a pathologic diagnosis of Kikuchi disease in the axillary lymph node by sonographically guided core needle biopsy (n=6) or excisional biopsy (n=1) were reviewed.
  • On sonograms, lymph nodes were assessed for their distribution, size, shape, border, echogenicity, and internal architecture, and those sonographic features of each node were evaluated to determine whether the findings favored malignant or benign lymphadenopathy.
  • RESULTS: Of the 7 patients (1 man and 6 women; mean age +/- SD, 34.3+/-7.7 years), 29 affected lymph nodes (5-38 mm; mean, 14.8+/-7.2 mm) were identified on sonograms.
  • The sonographic characteristics were as follows: the shortest axis/longest axis ratio of the node (mean, 0.595) was 0.5 or greater in 22 nodes (76%); the border was sharp in 16 (55%); the cortex was hypoechoic in 20 (69%) and isoechoic in 9 (31%); the hilum was narrow in 1 (4%) and absent in 16 (55%); and cortical thickening was found in 13 (45%, concentric in 6 and eccentric in 7).
  • Nineteen lymph nodes (66%) were classified as having malignant-favoring features, and 10 (34%) were classified as having benign-favoring features.
  • CONCLUSIONS: Many axillary lymph nodes in Kikuchi disease look suspicious sonographically.
  • When lymph nodes in the axilla show suspicious findings on sonograms of relatively young patients, Kikuchi disease can be considered a possible differential diagnosis, and image-guided percutaneous biopsy should be done.

  • Genetic Alliance. consumer health - Kikuchi disease.
  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18499844.001).
  • [ISSN] 0278-4297
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Picardi M, Ciancia R, De Renzo A, Montante B, Ciancia G, Zeppa P, Lobello R, Pane F, D'Agostino D, Nicolai E, Sirignano C, Salvatore M, Rotoli B: Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective study. Haematologica; 2006 Jul;91(7):960-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective study.
  • [MeSH-major] Hodgkin Disease / ultrasonography. Lymph Nodes / ultrasonography. Ultrasonography, Doppler / methods

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16818285.001).
  • [ISSN] 1592-8721
  • [Journal-full-title] Haematologica
  • [ISO-abbreviation] Haematologica
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] Italy
  •  go-up   go-down


63. Larsen SS, Vilmann P, Krasnik M, Dirksen A, Clementsen P, Skov BG, Jacobsen GK: Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Lung Cancer; 2005 Apr;48(1):85-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging.
  • The sensitivity for lymph node metastases in the right paratracheal region (2/4R) was 67% for EUS-FNA versus 33% for MS (p=0.69).
  • The sensitivity for lymph node metastases in region 2/4L and/or 2/4R and/or 7 was 96% for EUS-FNA versus 24% for MS (p<0.01).
  • [MeSH-major] Endosonography. Lung Neoplasms / pathology. Lymphatic Metastasis / diagnosis. Mediastinoscopy. Neoplasm Staging / methods
  • [MeSH-minor] Aged. Biopsy. Biopsy, Needle. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Patient Selection. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Lung Cancer. 2005 Nov;50(2):273-4; author reply 275-6 [16112775.001]
  • (PMID = 15777974.001).
  • [ISSN] 0169-5002
  • [Journal-full-title] Lung cancer (Amsterdam, Netherlands)
  • [ISO-abbreviation] Lung Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] Ireland
  •  go-up   go-down


64. Iakovleva LA: [Prelymphoma as a stage of malignant lymphoma (baboon malignant lymphoma model)]. Vopr Onkol; 2008;54(3):338-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinico-morphological signs of prelymphoma were: hypoplasia, edema and discomplexation in lymph nodes, anemia and inflammatory, i. e. degenerative lesions of the skin and mucous membranes.
  • [MeSH-minor] Animals. Disease Models, Animal. Female. Male. Neoplasm Staging. Papio hamadryas. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18652240.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


65. [Diagnostics and treatment of differentiated cancer of the thyroid gland (clinical recommendations of conciliatory commission)]. Vestn Khir Im I I Grek; 2008;167(3):59-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The approaches to the volume of surgery on the thyroid and lymph nodes of the neck, the parameters of staging the tumor process are shown.

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18652216.001).
  • [ISSN] 0042-4625
  • [Journal-full-title] Vestnik khirurgii imeni I. I. Grekova
  • [ISO-abbreviation] Vestn. Khir. Im. I. I. Grek.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article; Practice Guideline
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


66. Bley TA, Tittelbach-Helmrich D, Baumann T, Pache G, Ludwig U, Ghanem NA, Hopt UT, Langer M, Schaefer O: Sliding multislice MRI for abdominal staging of rectal gastrointestinal stromal tumours. In Vivo; 2007 Sep-Oct;21(5):891-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The staging of liver, malignant lymph nodes and bone metastases is now possible, prolonging pelvic MRI for only one minute.
  • [MeSH-minor] Aged. Humans. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18019430.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


67. Ragage F, Debled M, MacGrogan G, Brouste V, Desrousseaux M, Soubeyran I, de Lara CT, Mauriac L, de Mascarel I: Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer? Cancer; 2010 Jul 1;116(13):3093-101
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
  • BACKGROUND: Lymphovascular invasion (LVI) is a widely recognized prognostic factor in lymph node-negative breast cancers.
  • However, there are only limited and controversial data about its prognostic significance in lymph node-positive patients.
  • METHODS: Among 931 patients operated on and monitored at the authors' institution for an invasive breast carcinoma between 1989 and 1992, all 374 lymph node-positive breast cancers entered the study (median follow-up, 126 months).
  • RESULTS: LVI was present in 46% of tumors and was associated with age < or = 40 years (P = .02), high histological grade (P = .01), and negative estrogen receptor status (P = .032), but not with tumor size, number of involved lymph nodes, or HER-2/neu status.
  • Furthermore, in HER-2/neu-negative/hormone receptor-positive (n = 287) tumors, the number of independent prognostic factors (LVI, age, histological grade, number of involved lymph nodes, and tumor size) was associated with a 5-years metastasis-free survival ranging from 100% if no factors (n = 25) to 89% +/- 2% if 1 or 2 factors (n = 186) and 67% +/- 6 if 3, 4, or 5 factors (n = 76) were present (P < .001).
  • CONCLUSIONS: LVI is an independent prognostic factor in lymph node-positive breast cancer and merits further prospective investigations as a decision tool in the adjuvant chemotherapy setting.
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Female. Humans. Lymphatic Metastasis / pathology. Neoplasm Metastasis. Prognosis


68. Singh-Gupta V, Zhang H, Yunker CK, Ahmad Z, Zwier D, Sarkar FH, Hillman GG: Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy. Pharm Res; 2010 Jun;27(6):1115-27
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, pure genistein promoted increased metastasis to lymph nodes.
  • METHODS: Mice bearing PC-3 prostate tumors were treated with daidzein, genistein or both, and with tumor irradiation.
  • RESULTS: Daidzein did not increase metastasis to lymph nodes and acted as a radiosensitizer for prostate tumors.
  • [MeSH-minor] Androgens / metabolism. Animals. Cell Line, Tumor. Cell Proliferation / drug effects. Cell Proliferation / radiation effects. DNA / metabolism. DNA-(Apurinic or Apyrimidinic Site) Lyase / metabolism. Gene Expression Regulation, Neoplastic / drug effects. Gene Expression Regulation, Neoplastic / radiation effects. Humans. Hypoxia-Inducible Factor 1, alpha Subunit / genetics. Hypoxia-Inducible Factor 1, alpha Subunit / metabolism. Lymph Nodes / drug effects. Lymph Nodes / pathology. Lymph Nodes / radiation effects. Male. Mice. NF-kappa B / metabolism


69. Ishii H, Chikamatsu K, Sakakura K, Miyata M, Furuya N, Masuyama K: Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma. Oral Oncol; 2010 May;46(5):373-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.
  • The main factor that affects the prognosis of patients with oral squamous cell carcinoma (OSCC) is regional lymph node metastases, which usually spreads first to the sentinel lymph nodes (SLNs).
  • Recent studies have demonstrated that tumor cells in several malignancies can induce lymphangiogenesis in SLNs before metastasizing.
  • To elucidate the mechanisms of tumor dissemination of OSCC, we investigated whether primary tumors induce lymphangiogenesis within SLNs in patients with OSCC.
  • The mRNA expression of lymphatic-specific markers, including VEGFR-3, Prox-1, and LYVE-1 in 23 metastasis-negative SLNs obtained from 10 patients with OSCC, was investigated using a quantitative real-time RT-PCR assay, and compared with control lymph nodes from patients with non-cancerous diseases.
  • In addition, VEGF-C and VEGF-D expressions of the primary tumor were examined by immunohistochemistry.
  • Interestingly, the level of LYVE-1 expression in SLNs, despite the absence of metastasis, was significantly higher than in control lymph nodes.
  • Moreover, SLNs from patients with VEGF-C-positive tumor showed a significantly higher expression of VEGFR-3 than those from patients with VEGF-C-negative tumor.
  • Our findings suggest that in OSCC, the primary tumor actively induces lymphangiogenesis in SLNs prior to the onset of metastases, and where tumor-derived VEGF-C plays an important role.
  • [MeSH-minor] Aged. Aged, 80 and over. Female. Gene Expression Regulation, Neoplastic / genetics. Humans. Immunohistochemistry. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Proteins / physiology. Prognosis. Reverse Transcriptase Polymerase Chain Reaction. Vascular Endothelial Growth Factor A / metabolism

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Oral squamous cell carcinoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20308006.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


70. Khaled A, Sfia M, Fazaa B, Kourda N, Zermani R, Baccouche K, Ben Jilani S, Kamoun MR: [Chronic prurigo revealing an angioimmunoblastic T cell lymphoma]. Tunis Med; 2009 Aug;87(8):534-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On histology, the lymph nodes were composed of polymorphous lymphoid proliferation made of middle to large sized cells with clusters of epithelioid cells and post-capillary veinules hyperplasia.
  • Molecular biological analysis of a lymph node showed a T cell clonal proliferation.
  • The diagnosis of angio-immunoblastic T cell lymphoma was made.
  • The abdomino-pelvian CT scanner showed multiple inter-aortico-cave lymph nodes and a splenomegaly.
  • [MeSH-major] Immunoblastic Lymphadenopathy / diagnosis. Lymphoma, T-Cell / diagnosis. Paraneoplastic Syndromes / diagnosis. Prurigo / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20180359.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Tunisia
  •  go-up   go-down


71. Park S, Holmes-Tisch AJ, Cho EY, Shim YM, Kim J, Kim HS, Lee J, Park YH, Ahn JS, Park K, Jänne PA, Ahn MJ: Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J Thorac Oncol; 2009 Jul;4(7):809-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.
  • Given the heterogeneity of NSCLC at the molecular level, this study was conducted to determine the discrepancy in EGFR mutations between primary tumors and the corresponding lymph node metastasis.
  • PATIENTS AND METHODS: Surgically resected 101 paired primary NSCLC and metastatic lymph nodes were evaluated for the EGFR mutations by direct DNA sequencing and heteroduplex analysis.
  • RESULTS: EGFR mutation was detected in 29.7% (30 of 101) of the primary tumors and in 27.7% of lymph node metastases (28 of 101) by either direct sequencing or heteroduplex analysis, respectively.
  • In 11 cases, EGFR mutations were detected only in the primary tumor, whereas 1 case only in lymph node metastases.
  • Ten cases were primary tumor positive and lymph node negative, whereas seven cases were lymph node positive and primary tumor negative.
  • CONCLUSIONS: A considerable proportion of NSCLC showed discrepancy in EGFR mutations between primary tumors and metastatic lymph nodes, suggesting tumor heterogeneity at the molecular level during the process of metastasis.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Chi-Square Distribution. Female. Heteroduplex Analysis. Humans. Male. Middle Aged. Sequence Analysis, DNA


72. Qian X, Jin L, Hayden RT, Macon WR, Lloyd RV: Diagnosis of cat scratch disease with Bartonella henselae infection in formalin-fixed paraffin-embedded tissues by two different PCR assays. Diagn Mol Pathol; 2005 Sep;14(3):146-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis of cat scratch disease with Bartonella henselae infection in formalin-fixed paraffin-embedded tissues by two different PCR assays.
  • Clinical history and histologic findings are often insufficient to establish a definitive diagnosis of CSD.
  • We retrospectively studied formalin-fixed, paraffin-embedded (FFPE) lymph nodes from 35 patients with histologically suspected CSD by 2 different PCR assays and immunohistochemistry (IHC).
  • Twenty-two lymph nodes without morphologic evidence or a history of CSD were negative by PCR and immunostaining.
  • Our data indicate that detection of Bartonella DNA by PCR is useful to confirm the diagnosis of CSD.
  • [MeSH-major] Bartonella henselae / isolation & purification. Cat-Scratch Disease / diagnosis. Lymph Nodes / microbiology. Paraffin Embedding. Polymerase Chain Reaction / methods

  • Genetic Alliance. consumer health - Cat Scratch Disease.
  • MedlinePlus Health Information. consumer health - Cat Scratch Disease.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FORMALDEHYDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16106195.001).
  • [ISSN] 1052-9551
  • [Journal-full-title] Diagnostic molecular pathology : the American journal of surgical pathology, part B
  • [ISO-abbreviation] Diagn. Mol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / DNA, Bacterial; 0 / DNA, Ribosomal; 0 / Fixatives; 0 / RNA, Ribosomal, 16S; 1HG84L3525 / Formaldehyde; EC 2.3.3.1 / Citrate (si)-Synthase
  •  go-up   go-down


73. Ivanov S: [Some new tendencies in diagnosis and complex treatment of vulvar cancer--our and foreign experience]. Akush Ginekol (Sofiia); 2010;49(1):24-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Some new tendencies in diagnosis and complex treatment of vulvar cancer--our and foreign experience].
  • INTRODUCTION: The aim of this research work was to summarize our and foreign experience in the field of diagnosis, complex treatment and prognostic factors connected with vulvar cancer.
  • Older age and metastases in lymph nodes were independent bad prognostic factors.
  • The stages of the lymph nodes, LVSI and the stage were connected with survival and disease free survival.
  • Our main idea was to show some new tendencies in the latest 10 years towards relatively more conservative treatment of this neoplasia.
  • [MeSH-major] Vulvar Neoplasms / diagnosis. Vulvar Neoplasms / surgery
  • [MeSH-minor] Drug Therapy. Female. Humans. Lymph Nodes / pathology. Lymphatic Metastasis / pathology. Prognosis. Recurrence. Survival Rate

  • Genetic Alliance. consumer health - Vulvar cancer.
  • MedlinePlus Health Information. consumer health - Vulvar Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20734663.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


74. Fernández JG, Fernández-de-Mera I, Reyes LE, Ferreras MC, Pérez V, Gortazar C, Fernández M, García-Marín JF: Comparison of three immunological diagnostic tests for the detection of avian tuberculosis in naturally infected red deer (Cervus elaphus). J Vet Diagn Invest; 2009 Jan;21(1):102-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Macroscopically, the 3 animals showed tuberculous lesions located mainly in lymph nodes of the digestive system and small intestine but also in other organs and lymph nodes.
  • [MeSH-minor] Animals. Female. Lymph Nodes / microbiology. Lymph Nodes / pathology. Male. Skin Tests / veterinary

  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19139508.001).
  • [ISSN] 1040-6387
  • [Journal-full-title] Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
  • [ISO-abbreviation] J. Vet. Diagn. Invest.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


75. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, Fujii H: Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer; 2008 Nov 4;99(9):1462-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we investigated HLA class I expression in oesophageal squamous cell carcinoma (ESCC) (n=70) and in their metastatic lesions (lymph nodes (n=40) and liver (n=3)), by immunohistochemistry with anti-HLA class I monoclonal antibody (EMR8-5).
  • As a result, the downregulation of HLA class I expression in primary lesions of ESCC was observed in 43%, and that in metastatic lymph nodes was noted in 90%.

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer Suppl. 1991;6:95-100 [2066187.001]
  • [Cites] Cancer Res. 1991 Jan 15;51(2):729-36 [1985791.001]
  • [Cites] J Clin Pathol. 1995 Jun;48(6):539-44 [7665697.001]
  • [Cites] Eur J Cancer. 1996 Jan;32A(1):141-5 [8695222.001]
  • [Cites] Immunol Today. 1997 Feb;18(2):89-95 [9057360.001]
  • [Cites] Br J Cancer. 1997;76(7):836-44 [9328140.001]
  • [Cites] Int J Cancer. 1997 Dec 19;74(6):582-7 [9421352.001]
  • [Cites] Am J Pathol. 1999 Mar;154(3):745-54 [10079252.001]
  • [Cites] Clin Cancer Res. 2005 Jan 1;11(1):67-72 [15671529.001]
  • [Cites] Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):498-504 [15701833.001]
  • [Cites] Cancer Immunol Immunother. 2006 Aug;55(8):891-9 [16187081.001]
  • [Cites] Cancer Res. 2006 Sep 15;66(18):9281-9 [16982773.001]
  • [Cites] J Gastrointest Surg. 1997 Jul-Aug;1(4):316-23 [9834364.001]
  • [Cites] Cancer Sci. 2006 Dec;97(12):1374-80 [16995877.001]
  • [Cites] J Urol. 2007 Apr;177(4):1269-72; discussion 1272 [17382705.001]
  • [Cites] Tissue Antigens. 2007 Apr;69 Suppl 1:264-8 [17445216.001]
  • [Cites] Cancer Sci. 2007 Sep;98(9):1424-30 [17645781.001]
  • [Cites] J Clin Oncol. 2007 Sep 10;25(26):4110-7 [17827461.001]
  • [Cites] Cancer Immunol Immunother. 2008 Feb;57(2):197-206 [17622526.001]
  • [Cites] Cancer Immunol Immunother. 2008 May;57(5):601-9 [17874100.001]
  • [Cites] J Surg Oncol. 2008 Apr 1;97(5):451-5 [18247377.001]
  • [Cites] Cancer Sci. 2008 Jul;99(7):1448-54 [18452554.001]
  • [Cites] Cancer Immunol Immunother. 2008 Nov;57(11):1719-26 [18408926.001]
  • [Cites] Cancer Immunol Immunother. 2008 Dec;57(12):1903-10 [18317754.001]
  • [Cites] Adv Immunol. 2000;74:181-273 [10605607.001]
  • [Cites] J Exp Med. 2001 Sep 17;194(6):833-46 [11560998.001]
  • [Cites] Carcinogenesis. 2001 Oct;22(10):1615-23 [11577000.001]
  • [Cites] Surgery. 2003 May;133(5):486-94 [12773976.001]
  • [Cites] J Clin Oncol. 2003 Dec 15;21(24):4592-6 [14673047.001]
  • [Cites] Ann Surg. 1994 Sep;220(3):364-72; discussion 372-3 [8092902.001]
  • (PMID = 18841157.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Histocompatibility Antigens Class I
  • [Other-IDs] NLM/ PMC2579690
  •  go-up   go-down


76. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Ohro S, Tatebe S, Tsujitani S, Ikeguchi M: Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology; 2007 Mar;54(74):620-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
  • Micrometastases within lymph nodes were determined by immunohistochemistry using anti-cytokeratin antibody in node-negative early gastric cancer patients with recurrence.
  • The prognosis was poorer when the patients were older, and the depth of invasion was greater, lymph node metastasis, lymphatic involvement, and vascular involvement were present, and lymph node dissection was limited.
  • The independent prognostic factors were lymph node metastasis, lymph node dissection, and age by multivariate analysis using Cox proportional hazards.
  • Micrometastases within lymph nodes were confirmed in 3 of 6 node-negative patients with recurrence.
  • CONCLUSIONS: When patients have lymph node metastases or are older, close and long-term follow-up and careful planning of postoperative adjuvant therapy might be necessary to avoid recurrence.
  • [MeSH-major] Adenocarcinoma / pathology. Lymph Nodes / pathology. Lymphatic Metastasis / pathology. Neoplasm Recurrence, Local / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Age Factors. Aged. Aged, 80 and over. Female. Follow-Up Studies. Gastrectomy. Humans. Immunoenzyme Techniques. Keratins / analysis. Lymph Node Excision. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplastic Cells, Circulating. Peritoneal Neoplasms / pathology. Peritoneal Neoplasms / secondary. Prognosis. Proportional Hazards Models

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17523336.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 68238-35-7 / Keratins
  •  go-up   go-down


77. Cervinková M, Mandáková P, Síma P: Changes in proliferation activity and relative distributions of lymphoid cell subpopulations in congenitally athymic nu/nu mice and Lurcher mice with spontaneous olivopontocerebellar degeneration. Folia Microbiol (Praha); 2006;51(5):497-505
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Changes observed in mice with congenital damage of some part of the CNS-neuroendocrine-immune regulatory system are described. nu/nu mice with congenital absence of thymus and Lurcher mice with spontaneous olivopontocerebellar degeneration displayed changes in the histoarchitecture of adrenal gland, immune organs (thymus, spleen, axillar lymph nodes) and intestine.
  • Changes were also observed in IgM+, IgG+, CD4+ and CD8+ lymphoid cell subpopulations in the main lymphoid organs--the spleen and axillar lymph nodes and in the proliferative ability of whole lymphoid cell populations.
  • On the other hand, a relative increase of B-cell subpopulations was found in this mouse strain.
  • [MeSH-major] Adrenal Glands / pathology. Lymph Nodes / pathology. Lymphocytes / cytology. Mice, Neurologic Mutants / immunology. Mice, Nude / immunology. Spleen / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FASEB J. 1995 May;9(8):611-8 [7768352.001]
  • [Cites] Methods Cell Biol. 1994;41:211-7 [7861964.001]
  • [Cites] Methods Enzymol. 1984;108:197-241 [6396481.001]
  • [Cites] Br J Cancer. 1990 Nov;62(5):786-90 [2245171.001]
  • [Cites] Cytometry. 1998 Dec 1;33(4):487-91 [9845445.001]
  • [Cites] Science. 1969 Nov 7;166(3906):747-9 [4898615.001]
  • [Cites] Clin Chim Acta. 1992 Oct 30;211(3):S13-27 [1458606.001]
  • [Cites] Brain Res Brain Res Rev. 1995 Nov;21(3):246-84 [8806016.001]
  • [Cites] Springer Semin Immunopathol. 1993;14(3):221-38 [8094904.001]
  • [Cites] Trends Endocrinol Metab. 1994 Sep;5(7):303-9 [18407223.001]
  • [Cites] Science. 1982 Mar 19;215(4539):1534-6 [7063864.001]
  • [Cites] J Leukoc Biol. 1995 Aug;58(2):137-50 [7643009.001]
  • [Cites] Folia Morphol (Praha). 1970;18(3):293-5 [4194324.001]
  • (PMID = 17176774.001).
  • [ISSN] 0015-5632
  • [Journal-full-title] Folia microbiologica
  • [ISO-abbreviation] Folia Microbiol. (Praha)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


78. Nagata M, Takayama T, Nishijima N, Mugiya S, Ushiyama T, Ozono S: [Clinical course of patient with malignant pheochromocytoma who was treated with CVD chemotherapy and alpha-methyl-p-tyrosine]. Nihon Hinyokika Gakkai Zasshi; 2010 May;101(4):615-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The CT scan and bone scintigraphy showed right adrenal tumor, along with liver metastasis, lymph nodes swelling around aorta and multiple bone metastases.

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • Hazardous Substances Data Bank. DACARBAZINE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20535990.001).
  • [ISSN] 0021-5287
  • [Journal-full-title] Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology
  • [ISO-abbreviation] Nippon Hinyokika Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; 5J49Q6B70F / Vincristine; 658-48-0 / alpha-Methyltyrosine; 7GR28W0FJI / Dacarbazine; 8N3DW7272P / Cyclophosphamide; CVD protocol
  •  go-up   go-down


79. Inoue M, Ishioka J, Kageyama Y, Fukuda H, Higashi Y: [Primary malignant melanoma of the male urethra: a case report]. Hinyokika Kiyo; 2008 Apr;54(4):305-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A hemorrhagic black tumor and surrounding tan-colored flat lesions were observed at the distal urethra on urethroscopy.
  • Because of negative sentinel biopsy of inguinal lymph nodes, further lymph nodes exploration was omitted.
  • However, recurrent tumors at the perineal region and metastases to pelvic lymph nodes appeared four months after surgery, and he died eleven months later.

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18516927.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


80. Pan TC, Zheng Z, Li J, Chen T, Liu LG, Wei X: [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer]. Ai Zheng; 2007 Mar;26(3):303-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
  • BACKGROUND & OBJECTIVE: There is no agreement on the appropriate extent of lymph node dissection for lung cancer, especially for early non-small cell lung cancer (NSCLC).
  • This study was to explore the appropriate extent of lymph node dissection for early NSCLC by investigating the metastasis regulations of hilar and mediastinal lymph nodes.
  • The removed lymph nodes were subjected for pathologic examination.
  • The metastasis regulations of hilar and mediastinal lymph nodes were investigated.
  • RESULTS: A total of 295 groups of lymph nodes were removed.
  • Among them, 42 (14.2%) groups had metastasis, including 33 groups of hilar lymph nodes and 9 of mediastinal lymph nodes.
  • Four patients had mediastinal lymph node metastasis in the 7th station, 2 in the 5th station, 2 in the 9th station, and 1 in the 4th station.
  • The patients with tumors in the upper lobe had metastasis in the 5th or 7th station lymph nodes; the patients with tumors in the middle or lower lobe had metastasis in the 4th, 7th, or 9th station.
  • CONCLUSIONS: The metastasis regulations of hilar and mediastinal lymph nodes in Ia stage NSCLC is accordant to regional lymph node drainage regulations.
  • Selective regional lymph node dissection might be applied in these patients, that is, upper mediastinal lymph node, not lower mediastinal lymph node, should be removed when the tumor is in the upper lobe without hilar or subcarinal lymph node metastasis, while all mediastinal lymph nodes should be removed when the tumor is in the middle or lower lobe.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / surgery. Lymph Node Excision / methods
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adult. Aged. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Female. Follow-Up Studies. Humans. Lung / pathology. Lymph Nodes / surgery. Lymphatic Metastasis. Male. Mediastinum / pathology. Mediastinum / surgery. Middle Aged. Neoplasm Staging. Pneumonectomy / methods. Survival Rate


81. Yoneto T, Yoshikawa K, Fujii Y: [A patient with recurrent gallbladder cancer responding to chemotherapy with CDDP/CPT-11 and gemcitabine]. Gan To Kagaku Ryoho; 2005 Jan;32(1):99-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Before admission, she had undergone expanded cholecystectomy and had been treated successfully with 5-FU for 3 years to suppress the tumor growth in intraperitoneal lymph nodes.
  • The recurrence of the tumor in lymph nodes near the pancreas head was demonstrated by computer tomography.
  • We tried a course of a combination chemotherapy consisting of CPT-11 and CDDP (40 mg CPT-11/body/day on day 1 and 10 mg CDDP/body/day on day 2-5) to reduce the size of the nodes.
  • The status of the nodes was not changed for a year.
  • Then, the lymph node started to enlarge again and obstructive jaundice appeared.
  • As a result, metastatic lymph nodes were reduced in size and the dilatation of the interhepatic bile duct disappeared.
  • No change was observed in the size of the metastatic lymph nodes for a year.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Camptothecin / analogs & derivatives. Deoxycytidine / analogs & derivatives. Gallbladder Neoplasms / drug therapy. Lymph Nodes / pathology. Neoplasm Recurrence, Local / drug therapy

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15675592.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 7673326042 / irinotecan; B76N6SBZ8R / gemcitabine; Q20Q21Q62J / Cisplatin; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


82. de Bazelaire C, Farges C, Mathieu O, Zagdanski AM, Bourrier P, Frija J, de Kerviler E: Blunt-tip coaxial introducer: a revisited tool for difficult CT-guided biopsy in the chest and abdomen. AJR Am J Roentgenol; 2009 Aug;193(2):W144-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: We describe a coaxial introducer provided with an additional blunt-tip stylet that allows safe access to difficult-to-reach lymph nodes in the chest, abdomen, and pelvis under CT control.
  • [MeSH-major] Biopsy / instrumentation. Lymph Nodes / pathology. Lymphoma / pathology. Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Biopsy.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19620417.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Miyake K, Moriyama M, Aizawa K, Nagano S, Inoue Y, Sadanaga A, Nakashima H, Nakamura S: Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol; 2008;18(1):86-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A male patient with pleural effusion, swelling of the submandibular glands, and swelling of the paraaortic, mediastinal, and pararenal lymph nodes was diagnosed with MD.

  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • Hazardous Substances Data Bank. PREDNISOLONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18094933.001).
  • [ISSN] 1439-7595
  • [Journal-full-title] Modern rheumatology
  • [ISO-abbreviation] Mod Rheumatol
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 9PHQ9Y1OLM / Prednisolone
  •  go-up   go-down


84. Cheema Y, Olson S, Elson D, Chen H: What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res; 2006 Aug;134(2):160-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Papillary microcarcinomas of the thyroid, defined as tumors measuring < or =10 mm, are believed to be a less aggressive subset of papillary cancers that behave more like benign lesions and are often more conservatively treated.
  • Of these patients, 10 were excluded because there was no record of tumor size.
  • The mean tumor size was 5.7 +/- 0.38 mm.
  • Of the 74 patients, 12 (16%) had lymph node metastases.
  • [MeSH-minor] Adult. Female. Humans. Iodine Radioisotopes / therapeutic use. Lymph Node Excision. Lymphatic Metastasis. Male. Neoplasm Recurrence, Local / epidemiology. Thyroidectomy / methods

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16780882.001).
  • [ISSN] 0022-4804
  • [Journal-full-title] The Journal of surgical research
  • [ISO-abbreviation] J. Surg. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  •  go-up   go-down


85. Fujii T, Watanabe M: [An additional role of FTY720 in chronic colitis]. Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb;32(1):7-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FTY720 is a sphingosine-1-phosphate receptor modulator, which inhibits T-cell egress from lymph nodes, thereby prevents pathogenic T cells from migrating towards disease sites.
  • Next, We demonstrated that FTY720 treatment suppresses the recirculation of CD4(+) T cells in splenectomized lymphotoxin-alpha(-/-) mice that lack lymph nodes and spleen.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19252372.001).
  • [ISSN] 1349-7413
  • [Journal-full-title] Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
  • [ISO-abbreviation] Nihon Rinsho Meneki Gakkai Kaishi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Immunosuppressive Agents; 0 / Propylene Glycols; G926EC510T / Fingolimod Hydrochloride; NGZ37HRE42 / Sphingosine
  •  go-up   go-down


86. Sancho M, Vieira JM, Casalou C, Mesquita M, Pereira T, Cavaco BM, Dias S, Leite V: Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol; 2006 Oct;191(1):229-38
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The chemokine receptor CCR7 plays a critical role in lymphocyte and dendritic cell trafficking into and within lymph nodes, the preferential metastatic site for papillary (PTC) and medullary (MTC) thyroid carcinomas.
  • CCR7 expression was ninefold higher in classic compared with follicular variants of PTCs, and its expression in MTCs was significantly correlated with lymph node metastases.
  • Immunohistochemical staining for CCR7 showed protein expression in neoplastic thyroid cells, with higher intensity in PTCs, MTCs and their lymph node metastases (LNMs).
  • Taken together, our results demonstrate that CCR7 activation on thyroid carcinoma cells by CCL21 - a chemokine abundantly expressed in lymph nodes - favours tissue invasion and cell proliferation, and therefore may promote thyroid carcinoma growth and LNM.
  • [MeSH-major] Carcinoma, Papillary / metabolism. Lymph Nodes / metabolism. Receptors, Chemokine / metabolism. Thyroid Neoplasms / metabolism
  • [MeSH-minor] Actins / analysis. Antigens, CD29 / analysis. Carcinoma, Papillary, Follicular / metabolism. Cell Line, Tumor. Cell Membrane / chemistry. Cell Movement / drug effects. Chemokine CCL21. Chemokines, CC / pharmacology. Flow Cytometry. Humans. Immunohistochemistry / methods. Lymphatic Metastasis. Matrix Metalloproteinases / analysis. Receptors, CCR7. Reverse Transcriptase Polymerase Chain Reaction. Thyroid Gland / chemistry. Thyroid Gland / metabolism

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17065406.001).
  • [ISSN] 0022-0795
  • [Journal-full-title] The Journal of endocrinology
  • [ISO-abbreviation] J. Endocrinol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD29; 0 / CCL21 protein, human; 0 / CCR7 protein, human; 0 / Chemokine CCL21; 0 / Chemokines, CC; 0 / Receptors, CCR7; 0 / Receptors, Chemokine; EC 3.4.24.- / Matrix Metalloproteinases
  •  go-up   go-down


87. Hollerweger A, Macheiner P, Hübner E, Gritzmann N: Axillary sentinel lymph-node biopsy: gamma probe assisted sonographic localisation. Ultraschall Med; 2006 Feb;27(1):34-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Axillary sentinel lymph-node biopsy: gamma probe assisted sonographic localisation.
  • AIM: To evaluate axillary sentinel lymph-node (SLN) identification and localisation with gamma probe-assisted sonography.
  • After the acquisition of images with the gamma camera, the delineated lymph nodes were marked on the skin.
  • Node activity was controlled intraoperatively.
  • Multiple SLNs at different sites, all with similar activity, were demonstrated in one patient, while in another patient the sonographically visible lymph nodes were too small for exact correlation.
  • [MeSH-major] Lymph Nodes / ultrasonography. Sentinel Lymph Node Biopsy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16470477.001).
  • [ISSN] 0172-4614
  • [Journal-full-title] Ultraschall in der Medizin (Stuttgart, Germany : 1980)
  • [ISO-abbreviation] Ultraschall Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


88. Yano M, Yasuda T, Miyata H, Fujiwara Y, Takiguchi S, Monden M: Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus. J Surg Oncol; 2005 Mar 15;89(4):244-50; discussion 250
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND OBJECTIVES: Although the histological effectiveness of preoperative chemoradiotherapy against the main tumor is reported to be the strongest prognostic factor for patients with esophageal cancer, it remains unknown whether such chemoradiotherapy is equally effective against metastatic lymph nodes.
  • The histological effectiveness against the main tumor of the chemoradiotherapy was correlated with lymph mode metastasis and other clinico-pathological factors.
  • RESULTS: The histological effectiveness against the main tumor was grade 3 in 26 patients, grade 2 in 49 and grade 1 in 28.
  • The number of pathological node-negative patients was 21 (80.8%), 19 (38.8%), and 7 (25.0%) in those having grade 3, 2, and 1 responses of their main tumors, respectively.
  • The average number of pathological metastatic lymph nodes was 0.19, 1.4, and 4.4 in patients with grade 3, 2, and 1 responses, respectively.
  • Most patients with main tumors of pathological CR are node-negative.
  • Patients with a grade 2 response have at most a few positive nodes.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carcinoma, Squamous Cell / pathology. Esophageal Neoplasms / pathology. Lymph Nodes / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 Wiley-Liss, Inc.
  • (PMID = 15726612.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil; 5-FU-CDDP protocol
  •  go-up   go-down


89. Jeruss JS, Newman LA, Ayers GD, Cristofanilli M, Broglio KR, Meric-Bernstam F, Yi M, Waljee JF, Ross MI, Hunt KK: Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer; 2008 Jun 15;112(12):2646-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.
  • BACKGROUND: The utility of sentinel lymph node (SNL) biopsy (SLNB) as a predictor of axillary lymph node status is similar in patients who receive neoadjuvant chemotherapy and patients who undergo surgery first.
  • At the time of presentation, 66 patients had clinically negative lymph nodes by ultrasonography, and 38 patients had positive lymph nodes confirmed by fine-needle aspiration.
  • RESULTS: Patients with clinically negative lymph nodes at presentation were less likely than patients with positive lymph nodes to have positive non-SLNs (47% vs 71%; P=.017).
  • On multivariate analysis, lymphovascular invasion, the method for detecting SLN metastasis, multicentricity, positive axillary lymph nodes at presentation, and pathologic tumor size retained grouped significance with a bootstrap-adjusted area under the curve (AUC) of 0.762.
  • [MeSH-minor] Adult. Aged. Databases as Topic. Female. Humans. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Neoadjuvant Therapy. Predictive Value of Tests. Sentinel Lymph Node Biopsy

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 American Cancer Society.
  • (PMID = 18442039.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016672
  • [Publication-type] Journal Article; Validation Studies
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS668480; NLM/ PMC4365777
  •  go-up   go-down


90. Funahashi K, Koike J, Shimada M, Okamoto K, Goto T, Teramoto T: A preliminary study of the draining lymph node basin in advanced lower rectal cancer using a radioactive tracer. Dis Colon Rectum; 2006 Oct;49(10 Suppl):S53-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A preliminary study of the draining lymph node basin in advanced lower rectal cancer using a radioactive tracer.
  • PURPOSE: This study was designed to examine the draining lymph node basin at highest risk of metastasis in lower rectal cancer using 99 mTc-tin colloid.
  • METHODS: In 43 patients, the area with highest hot nodes density was defined as the draining lymph node basin using a gamma probe.
  • Metastatic states of all removed lymph nodes were examined histologically.
  • RESULTS: A total of 203 hot nodes were identified in 39 patients (91 percent) with a mean of 5.2 nodes.
  • The number of removed lymph nodes was 808 nodes: 670 nodes in the mesorectum, and 138 nodes in the pelvis.
  • In 21 patients, the metastatic states of 119 nodes were investigated histologically.
  • From the distribution of the identified hot nodes, the draining lymph node basins were classified into two patterns: lateral type (n = 17), and mesorectal type (n = 22).
  • Only 20 (17 percent) of 119 positive nodes were identified as hot node.
  • Tumor cells that occupied the lymph node diffusely or massively probably interfered with the exact diagnosis of metastasis.
  • Lymph node metastasis in the pelvis was observed in 5 patients (13 percent).
  • One false negative was of the mesorectal type with diffuse metastases in the para-aortic lymph nodes.
  • The remaining four patients were of the lateral type and all positive lymph nodes, including positive nonhot nodes, were located within the draining lymph node basin.
  • Consequently, in 20 (95.2 percent) of 21 patients with lymph node metastasis, all positive lymph nodes were located within the draining lymph node basin of the tumor.
  • CONCLUSIONS: Two types of the draining lymph node basin of advanced lower rectal cancer were identified using this method.
  • The concordance between lymph node metastases and the draining lymph node basin is good.
  • [MeSH-minor] Female. Humans. Lymph Node Excision. Male. Middle Aged. Neoplasm Staging. Risk Factors. Sentinel Lymph Node Biopsy. Technetium Compounds. Tin Compounds

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. TIN COMPOUNDS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17106816.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Technetium Compounds; 0 / Tin Compounds; 0 / technetium Tc 99m tin colloid
  •  go-up   go-down


91. Perez RO, Habr-Gama A, Nishida Arazawa ST, Rawet V, Coelho Siqueira SA, Kiss DR, Gama-Rodrigues JJ: Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis; 2005 Sep;20(5):434-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.
  • OBJECTIVE: The objective was to determine the presence and frequency of micrometastasis in lymph nodes of patients with rectal cancer treated by preoperative chemoradiation followed by curative resection.
  • Three 4-microm paraffin sections were obtained from each lymph node, cut at 50 microm apart from each other.
  • RESULTS: Mean number of lymph nodes was 9.6 per patient.
  • Four patients (7%) and seven lymph nodes (1.35%) were positive for micrometastasis.
  • Three patients had pT3 and one a pT4 tumor.
  • Lymph node micrometastasis was not associated with decreased overall or disease-free survival.
  • The identification of mucinous deposits on lymph nodes with no viable tumor cells may be direct evidence of lymph node downstaging.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant. Digestive System Surgical Procedures. Female. Fluorouracil / therapeutic use. Follow-Up Studies. Humans. Immunohistochemistry. Leucovorin / therapeutic use. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local. Neoplasm Staging. Radiotherapy, Adjuvant. Treatment Outcome. Vitamin B Complex / administration & dosage. Vitamin B Complex / therapeutic use

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2002 Oct 15;20(20):4232-41 [12377967.001]
  • [Cites] Surgery. 1993 Apr;113(4):365-72 [7681222.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1987 Jul;13(7):999-1006 [3597163.001]
  • [Cites] J Gastrointest Surg. 2004 Jan;8(1):56-62; discussion 62-3 [14746836.001]
  • [Cites] Gut. 1994 Oct;35(10):1447-8 [7525418.001]
  • [Cites] Clin Cancer Res. 2001 May;7(5):1350-7 [11350905.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):55-62 [2745208.001]
  • [Cites] J Gastroenterol. 1997 Dec;32(6):758-64 [9430013.001]
  • [Cites] J R Soc Med. 1992 Jul;85(7):386-8 [1378498.001]
  • [Cites] J Clin Gastroenterol. 1994 Oct;19(3):210-3 [7806831.001]
  • [Cites] Lab Invest. 1996 Oct;75(4):611-6 [8874391.001]
  • [Cites] Ann Surg Oncol. 2001 May;8(4):300-4 [11352302.001]
  • [Cites] Clin Cancer Res. 1999 Aug;5(8):2065-8 [10473087.001]
  • [Cites] N Engl J Med. 1990 Feb 8;322(6):352-8 [2300087.001]
  • [Cites] Clin Cancer Res. 2002 Mar;8(3):759-67 [11895906.001]
  • [Cites] Dis Colon Rectum. 1991 Oct;34(10):917-20 [1717210.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):246-50 [8996149.001]
  • [Cites] N Engl J Med. 1998 Jul 23;339(4):223-8 [9673300.001]
  • [Cites] Clin Chem. 1996 Sep;42(9):1369-81 [8787692.001]
  • [Cites] Dis Colon Rectum. 1998 Oct;41(10):1244-9 [9788387.001]
  • [Cites] Eur J Cancer. 1995 Jul-Aug;31A(7-8):1333-9 [7577046.001]
  • [Cites] Arch Surg. 2002 Feb;137(2):206-10 [11822961.001]
  • [Cites] Cancer. 1994 Feb 1;73(3):563-9 [7507795.001]
  • [Cites] Eur J Surg. 1996 Aug;162(8):637-42 [8891622.001]
  • [Cites] J Am Coll Surg. 2002 Feb;194(2):131-5; discussion 135-6 [11848629.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):583-96 [11309435.001]
  • [Cites] Dis Colon Rectum. 1998 Sep;41(9):1087-96 [9749491.001]
  • [Cites] J Pathol. 1994 Feb;172(2):183-7 [7513353.001]
  • [Cites] Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8 [15383798.001]
  • [Cites] Am J Clin Oncol. 1992 Oct;15(5):371-5 [1524036.001]
  • [Cites] Hepatogastroenterology. 2004 Nov-Dec;51(60):1703-7 [15532809.001]
  • (PMID = 15759124.001).
  • [ISSN] 0179-1958
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 12001-76-2 / Vitamin B Complex; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


92. Wang L, Li X, Li Y, Xue YW: [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features]. Ai Zheng; 2005 Jul;24(7):823-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND & OBJECTIVE: Survivin, an anti-apoptosis gene, expresses in most tumors, and takes part in tumor angiogenesis.
  • METHODS: MVD and expressions of Survivin and VEGF in 96 specimens of NSCLC tissues, 31 specimens of tumor adjacent tissues, and 20 specimens of benign lesions were detected by SP immunohistochemistry; their interrelations and correlations to clinicopathologic features of NSCLC were analyzed.
  • RESULTS: Positive rate of Survivin was significantly higher in NSCLC than in adjacent tissues and benign lesions (69.8% vs. 16.1% and 0, P<0.05); its expression was related with differentiation and TNM stage of NSCLC.
  • Positive rate of VEGF was significantly higher in NSCLC than in adjacent tissues and benign lesions (72.9% vs. 45.2% and 25.0%, P<0.05); its expression was related with lymph node metastasis and TNM stage of NSCLC.
  • MVD was significantly higher in NSCLC than in adjacent tissues and benign lesions (24.44+/-7.79 vs. 19.37+/-5.26 and 11.83+/-6.25, P<0.05), and was related with lymph node metastasis and TNM stage of NSCLC.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / pathology. Lung Neoplasms / pathology. Microtubule-Associated Proteins / metabolism. Neoplasm Proteins / metabolism. Neovascularization, Pathologic. Vascular Endothelial Growth Factor A / metabolism
  • [MeSH-minor] Adult. Aged. Female. Humans. Inhibitor of Apoptosis Proteins. Lymphatic Metastasis. Male. Microcirculation / pathology. Middle Aged. Neoplasm Staging. Tuberculoma / metabolism. Tuberculoma / pathology. Tuberculosis, Pulmonary / metabolism. Tuberculosis, Pulmonary / pathology

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16004808.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / Neoplasm Proteins; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


93. Ji Y, Zhang P, Lu Y, Ma D: Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication. J Huazhong Univ Sci Technolog Med Sci; 2006;26(3):359-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MTA2 expression in normal, borderline, benign and malignant epithelial ovarian tissues was immunohistochemically examined.
  • In borderline and malignant ovarian tissues tested, MTA2 staining was dramatically stronger than in normal and benign tissues (P < 0.01).
  • The expression of MTA2 was correlated with clinical stage, histopathological grade and lymph node metastasis.
  • [MeSH-minor] Adult. Aged. Blotting, Western. Cell Line, Tumor. Female. Humans. Lymphatic Metastasis. Middle Aged. Neoplasm Staging. RNA, Messenger / biosynthesis. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Ovarian epithelial cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2000 Nov 16;408(6810):377-81 [11099047.001]
  • [Cites] Semin Oncol. 2003 Oct;30(5 Suppl 16):30-7 [14613024.001]
  • [Cites] Genes Dev. 1999 Aug 1;13(15):1924-35 [10444591.001]
  • [Cites] J Hum Genet. 1999;44(1):52-6 [9929979.001]
  • [Cites] Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):434-7 [12974090.001]
  • (PMID = 16961294.001).
  • [ISSN] 1672-0733
  • [Journal-full-title] Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
  • [ISO-abbreviation] J. Huazhong Univ. Sci. Technol. Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Repressor Proteins; EC 3.5.1.- / MTA2 protein, human; EC 3.5.1.98 / Histone Deacetylases
  •  go-up   go-down


94. Goto T, Maeshima A, Oyamada Y, Kato R: Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer. Interact Cardiovasc Thorac Surg; 2010 Jun;10(6):1051-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer.
  • Serum immunoelectrophoresis detected IgG-lambda monoclonal protein; therefore, we suspected the coexistence of multiple myeloma, amyloidosis, benign macroglobulinemia, or benign monoclonal gammopathy.
  • Since the patient continued to expectorate large amounts of bloody sputum every day, and his anemia progressed, right upper lobectomy and lymph node dissection were performed on a semi-emergent basis without preoperative bone marrow examination.
  • The postoperative pathological diagnosis was SCC of the lung (p-T2N0M0, stage IB).
  • [MeSH-major] Carcinoma, Squamous Cell / surgery. Lung Neoplasms / surgery. Multiple Myeloma / diagnosis. Neoplasms, Multiple Primary. Ribs / pathology. Thoracotomy
  • [MeSH-minor] Biomarkers, Tumor / analysis. Humans. Immunohistochemistry. Lymph Node Excision. Male. Middle Aged. Neoplasm Staging. Tomography, X-Ray Computed


95. Persec Z, Persec J, Sović T, Romic Z, Bosnar Herak M, Hrgovic Z: Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml. Onkologie; 2010;33(3):110-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Due to the high specificity for prostate tissue, prostate-specific antigen (PSA) is the primary serum tumor marker for prostate cancer.
  • Computed tomography (CT) showed multiple liver metastases with retroperitoneal lymph nodes of up to 1 cm.
  • CONCLUSION: This case presents an asymptomatic prostate cancer patient with bone and liver metastasis, enlarged retroperitoneal lymph nodes and the highest PSA level published to date.
  • [MeSH-major] Biomarkers, Tumor / blood. Bone Neoplasms / blood. Bone Neoplasms / secondary. Liver Neoplasms / blood. Liver Neoplasms / secondary. Prostate-Specific Antigen / blood. Prostatic Neoplasms / blood


96. Song KY, Kim SN, Park CH: Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer: technical and oncologic aspects. Surg Endosc; 2008 Mar;22(3):655-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer: technical and oncologic aspects.
  • BACKGROUND: Laparoscopy-assisted distal gastrectomy (LADG) with lymph node dissection for advanced gastric cancer is still controversial.
  • To evaluate the technical and oncologic feasibility and advantage of LADG with D2 lymph node dissection, the authors compared the surgical outcomes of LADG with D2 dissection and those of conventional open distal gastrectomy (ODG) for patients with early gastric cancer (EGC).
  • METHODS: Between September 2004 and August 2005, the study enrolled 75 patients with a preoperative diagnosis of EGC.
  • All the patients received D2 lymph node dissection.
  • Their clinicopathologic characteristics, postoperative outcomes, and retrieved lymph nodes were compared at each station.
  • No significant differences were found in the total number of retrieved lymph nodes (37.2 vs 42.4; p > 0.05) or node stations (p > 0.05) between the two groups.
  • CONCLUSIONS: LADG with D2 lymph node dissection is a safe and feasible procedure, and it is oncologically compatible with open gastrectomy.
  • [MeSH-major] Laparoscopy / methods. Lymph Nodes / surgery. Neoplasm Invasiveness / pathology. Stomach Neoplasms / pathology. Stomach Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Chi-Square Distribution. Cohort Studies. Female. Follow-Up Studies. Gastrectomy / methods. Humans. Immunohistochemistry. Korea. Laparotomy / methods. Lymph Node Excision / methods. Male. Middle Aged. Neoplasm Staging. Probability. Risk Assessment. Sensitivity and Specificity. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dig Dis. 2005;23(2):113-8 [16352890.001]
  • [Cites] Lancet. 1996 Apr 13;347(9007):995-9 [8606613.001]
  • [Cites] Gastric Cancer. 1999 Nov;2(3):186-190 [11957094.001]
  • [Cites] J Am Coll Surg. 2003 Jan;196(1):75-81 [12517554.001]
  • [Cites] Surgery. 2002 Jan;131(1 Suppl):S306-11 [11821829.001]
  • [Cites] Br J Surg. 1997 Nov;84(11):1567-71 [9393281.001]
  • [Cites] Br J Surg. 1995 Mar;82(3):346-51 [7796005.001]
  • [Cites] Surgery. 1998 May;123(5):573-8 [9591011.001]
  • [Cites] Gastric Cancer. 2002;5(1):1-5 [12021853.001]
  • [Cites] Lancet. 1995 Mar 25;345(8952):745-8 [7891484.001]
  • [Cites] Gastric Cancer. 1998 Dec;1(1):10-24 [11957040.001]
  • [Cites] Surg Laparosc Endosc. 1994 Apr;4(2):146-8 [8180768.001]
  • [Cites] Surg Endosc. 2005 Dec;19(12):1592-6 [16247578.001]
  • [Cites] Gastric Cancer. 2000 Aug 4;3(1):50-55 [11984710.001]
  • [Cites] Surg Endosc. 2003 May;17(5):758-62 [12618942.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Dec;13(6):361-5 [14712095.001]
  • [Cites] J Am Coll Surg. 2004 Jun;198(6):933-8 [15194075.001]
  • (PMID = 17593447.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


97. Hakim AA, Terada KY: Sentinel node dissection in vulvar cancer. Curr Treat Options Oncol; 2006 Mar;7(2):85-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel node dissection in vulvar cancer.
  • Because only approximately 20% of patients with vulvar cancer have positive lymph nodes upon presentation, the traditional approach of inguinal-femoral lymphadenectomy for all patients resulted in many patients undergoing a morbid procedure without any real benefit.
  • Sentinel node dissection, by removing only the nodes with the highest risk of containing metastases, offers a much less morbid alternative.
  • In addition, because only one or two lymph nodes are removed, these can be subjected to a more thorough histopathologic analysis than conventional complete lymphadenectomy.
  • Therefore, sentinel node dissection with serial sectioning and immunohistochemical staining potentially offers a more accurate assessment of the regional nodes with less morbidity.
  • Patients with positive sentinel nodes may then undergo additional therapy.
  • Patients with negative sentinel nodes are theoretically at very low risk for metastases and should not require any additional treatment.
  • [MeSH-major] Sentinel Lymph Node Biopsy / methods. Vulvar Neoplasms / surgery
  • [MeSH-minor] Female. Humans. Lymph Node Excision / methods. Lymphatic Metastasis

  • Genetic Alliance. consumer health - Vulvar cancer.
  • MedlinePlus Health Information. consumer health - Vulvar Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Obstet Gynaecol Br Commonw. 1963 Oct;70:751-65 [14071836.001]
  • [Cites] Ann R Coll Surg Engl. 1948 Oct;3(4):187-209 [18889533.001]
  • [Cites] Am J Obstet Gynecol. 1975 Oct 15;123(4):349-55 [1166863.001]
  • [Cites] Gynecol Oncol. 2004 Jul;94(1):10-5 [15262113.001]
  • [Cites] Gynecol Oncol. 1998 Jul;70(1):65-9 [9698476.001]
  • [Cites] J Clin Oncol. 2000 Aug;18(15):2811-6 [10920128.001]
  • [Cites] Obstet Gynecol. 1992 Apr;79(4):490-7 [1553164.001]
  • [Cites] Gynecol Oncol. 2002 Mar;84(3):449-52 [11855886.001]
  • [Cites] Obstet Gynecol. 1994 Aug;84(2):163-7 [8041523.001]
  • [Cites] Ann Surg Oncol. 2002 Nov;9(9):823-5 [12417500.001]
  • [Cites] Gynecol Oncol. 2000 Jan;76(1):40-4 [10620439.001]
  • [Cites] Gynecol Oncol. 2005 Apr;97(1):151-4 [15790451.001]
  • [Cites] Arch Surg. 1992 Apr;127(4):392-9 [1558490.001]
  • [Cites] Gynecol Oncol. 2002 Jul;86(1):99-101 [12079308.001]
  • [Cites] Obstet Gynecol. 1983 Oct;62(4):457-62 [6888823.001]
  • [Cites] Gynecol Oncol. 2003 Jun;89(3):475-9 [12798714.001]
  • [Cites] Gynecol Oncol. 2004 Mar;92 (3):981-4 [14984971.001]
  • [Cites] J Am Coll Surg. 1998 Mar;186(3):275-83 [9510258.001]
  • [Cites] Gynecol Oncol. 1997 Sep;66(3):425-8 [9299256.001]
  • [Cites] Gynecol Oncol. 1995 Nov;59(2):216-20 [7590476.001]
  • [Cites] Am J Obstet Gynecol. 1979 Apr 1;133(7):825-32 [434024.001]
  • [Cites] Am J Obstet Gynecol. 1982 Jun 1;143(3):340-51 [7081350.001]
  • [Cites] Nuklearmedizin. 2001 Jun;40(3):80-5 [11475077.001]
  • [Cites] Am J Obstet Gynecol. 1974 Jan 15;118(2):159-62 [4809402.001]
  • [Cites] Ann Surg. 1994 Dec;220(6):759-67 [7986143.001]
  • (PMID = 16455019.001).
  • [ISSN] 1527-2729
  • [Journal-full-title] Current treatment options in oncology
  • [ISO-abbreviation] Curr Treat Options Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 29
  •  go-up   go-down


98. Ernst O: [Hyperparathyroidism: CT and MR findings]. J Radiol; 2009 Mar;90(3 Pt 2):409-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Hyperparathyroïdie: applications du scanner et de l'IRM.
  • Density measurements can assist in differentiating adenomas from lymph nodes and normal thyroid tissue.
  • Forty five seconds after contrast injection, adenomas have a density>130 HU, whereas lymph nodes have a density<130 HU.
  • Furthermore, between 45 and 70 seconds after injection, the attenuation of parathyroid adenomas decreases (>20UH) whereas the attenuation of lymph nodes increases.
  • [MeSH-minor] Contrast Media. Diagnosis, Differential. Female. Humans. Hypercalcemia / etiology. Lymph Nodes / radiography. Magnetic Resonance Imaging. Middle Aged. Parathyroid Glands / radiography. Sensitivity and Specificity. Time Factors

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19421131.001).
  • [ISSN] 0221-0363
  • [Journal-full-title] Journal de radiologie
  • [ISO-abbreviation] J Radiol
  • [Language] fre
  • [Publication-type] Case Reports; Comparative Study; English Abstract; Evaluation Studies; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 3
  •  go-up   go-down


99. Long CM, van Laarhoven HW, Bulte JW, Levitsky HI: Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res; 2009 Apr 1;69(7):3180-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.
  • A major parameter limiting immune responses to vaccination is the number of activated antigen-presenting cells (APC) that capture antigen and migrate to draining lymph nodes (LN).
  • Here, we describe an in vivo labeling method, which relies upon cell-to-cell transfer of superparamagnetic iron oxide (SPIO) from tumor cells to endogenous APCs, in situ, to quantify APC delivery to LNs in a tumor vaccine model.
  • Mice were immunized with a tumor cell-based vaccine that was irradiated and labeled with SPIO.
  • We show here that MRI is capable of monitoring, in vivo, the trafficking of magnetically labeled APCs inducing a tumor-specific immune response, and that these cells can be magnetically recovered ex vivo.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FERRIC OXIDE .
  • Hazardous Substances Data Bank. HEMATITE .
  • Hazardous Substances Data Bank. Imiquimod .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol. 2003 Dec 1;171(11):6275-82 [14634145.001]
  • [Cites] Blood. 2008 Jul 15;112(2):362-73 [18354038.001]
  • [Cites] Methods Enzymol. 2004;386:275-99 [15120257.001]
  • [Cites] Nat Med. 2004 May;10(5):475-80 [15122249.001]
  • [Cites] Nat Med. 2004 Sep;10(9):909-15 [15340416.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43 [8097319.001]
  • [Cites] J Exp Med. 1994 Apr 1;179(4):1215-24 [7908321.001]
  • [Cites] Science. 1994 May 13;264(5161):961-5 [7513904.001]
  • [Cites] Immunity. 1996 Apr;4(4):349-55 [8612129.001]
  • [Cites] J Exp Med. 1997 Jul 21;186(2):239-45 [9221753.001]
  • [Cites] J Exp Med. 1998 Sep 21;188(6):1075-82 [9743526.001]
  • [Cites] J Exp Med. 2000 Feb 7;191(3):541-50 [10662799.001]
  • [Cites] Immunity. 2000 Dec;13(6):783-94 [11163194.001]
  • [Cites] J Exp Med. 2001 Sep 17;194(6):707-17 [11560988.001]
  • [Cites] Nat Biotechnol. 2001 Dec;19(12):1141-7 [11731783.001]
  • [Cites] J Exp Med. 2002 Dec 16;196(12):1627-38 [12486105.001]
  • [Cites] Curr Opin Immunol. 2003 Feb;15(1):120-7 [12495743.001]
  • [Cites] Cancer Res. 2003 Jan 1;63(1):12-7 [12517769.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):440-7 [12722741.001]
  • [Cites] J Clin Oncol. 2003 Jun 15;21(12):2415-32 [12805342.001]
  • [Cites] Immunity. 2003 Jul;19(1):47-57 [12871638.001]
  • [Cites] J Exp Med. 2003 Aug 18;198(4):615-21 [12925677.001]
  • [Cites] Nat Immunol. 2003 Sep;4(9):907-12 [12910266.001]
  • [Cites] NMR Biomed. 2004 Nov;17(7):484-99 [15526347.001]
  • [Cites] Curr Opin Immunol. 2005 Apr;17(2):170-4 [15766677.001]
  • [Cites] Nat Biotechnol. 2005 Aug;23(8):983-7 [16041364.001]
  • [Cites] Magn Reson Med. 2005 Oct;54(4):769-74 [16161115.001]
  • [Cites] Nat Biotechnol. 2005 Nov;23(11):1407-13 [16258544.001]
  • [Cites] Nat Rev Immunol. 2006 May;6(5):383-93 [16622476.001]
  • [Cites] Immunity. 2006 Jul;25(1):153-62 [16860764.001]
  • [Cites] Immunobiology. 2006;211(6-8):587-97 [16920497.001]
  • [Cites] Eur J Immunol. 2006 Sep;36(9):2544-55 [16909432.001]
  • [Cites] Cancer Invest. 2003;21(6):873-86 [14735692.001]
  • (PMID = 19276358.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NIDA NIH HHS / DA / DA026299-01; United States / NIDA NIH HHS / DA / R01 DA026299; United States / NIDA NIH HHS / DA / R01 DA026299-01
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Aminoquinolines; 0 / Cancer Vaccines; 0 / Ferric Compounds; 1K09F3G675 / ferric oxide; 83869-56-1 / Granulocyte-Macrophage Colony-Stimulating Factor; 99011-02-6 / imiquimod
  • [Other-IDs] NLM/ NIHMS260080; NLM/ PMC3031988
  •  go-up   go-down


100. Moore J, Hyman N, Callas P, Littenberg B: Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival. Surgery; 2010 Mar;147(3):358-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.
  • BACKGROUND: Survival in colon cancer is greater in those patients who have more lymph nodes identified at resection and may be due to stage migration, confounding by treatment, social, or clinical characteristics.
  • Identifying factor(s) responsible for the effect may represent an opportunity to improve quality of care for patients with colon cancer by increasing node counts in specimens.
  • The primary predictor variable was the number of lymph nodes identified.
  • The models allowed adjustment for patient factors, use of chemotherapy, surgical specialty, and the average number of nodes identified by surgeon and hospital pathologist.
  • RESULTS: The number of nodes identified was related to survival.
  • Compared to those with less than 7 nodes, patients with 7 to 11 nodes had a 13% lesser risk of death (hazard ratio [HR], 0.87; 95% confidence interval [CI], 0.76-0.99; P = .037).
  • Patients with more than 12 nodes had a 17% lesser risk (HR, 0.83; 95% CI, 0.73-0.95; P = .005).
  • Adjusting for selected patient demographic characteristics, receipt of chemotherapy, surgical specialty, and the average number of nodes identified per specimen by the surgeon or hospital did not significantly alter the relationship between number of nodes and survival.
  • CONCLUSION: These findings argue against understaging or confounding as the explanation for the inferior survival observed in patients with fewer nodes identified.
  • National initiatives to increase the number of nodes identified in colon cancer specimens may not improve substantially the cancer-specific outcomes.
  • [MeSH-major] Colonic Neoplasms / mortality. Colonic Neoplasms / pathology. Diagnostic Errors. Lymph Node Excision. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 19962166.001).
  • [ISSN] 1532-7361
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / K24 DK68380; United States / NCRR NIH HHS / RR / K30 RR22260
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down






Advertisement